Prof Susanna Proudman
School of Medicine
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Dr Susanna Proudman graduated from Adelaide University in 1987 and trained in rheumatology at the Royal Adelaide Hospital where she is now Rheumatology Unit Director. As an ARA Michael Mason Fellow, she trained with Professor Paul Emery in Leeds, establishing one of the first Early Arthritis Clinics in the world.Recent research interests include “best practice” management of early rheumatoid arthritis with an emphasis on “treat-to-target” therapy, the role of omega-3 fatty acids and periodontal disease and standardized management of systemic sclerosis and pulmonary arterial hypertension. In establishing a “Centre of Excellence” for the treatment of PAH in SSc and as Chair of the Australian Scleroderma Interest Group, she established the Australian Scleroderma Cohort Study in 2007 with collaborations such as the International Systemic Sclerosis Inception Cohort (INSYNC) and the Scleroderma Clinical Trials Consortium Damage Index working group. She is Medical Director of Arthritis Australia and Chair of the Actelion Clinical Excellence Program.
My Research
Susanna Proudman graduated from Adelaide University in 1987 and trained in rheumatology at the Royal Adelaide Hospital where she is now Rheumatology Unit Director. As an ARA Michael Mason Fellow, she trained with Professor Paul Emery in Leeds, establishing one of the first Early Arthritis Clinics in the world.
Recent research interests include “best practice” management of early rheumatoid arthritis with an emphasis on “treat-to-target” therapy, the role of omega-3 fatty acids and periodontal disease and standardized management of systemic sclerosis and pulmonary arterial hypertension. In establishing a “Centre of Excellence” for the treatment of PAH in SSc and as Chair of the Australian Scleroderma Interest Group, she established the Australian Scleroderma Cohort Study in 2007 with collaborations such as the International Systemic Sclerosis Inception Cohort (INSYNC) and the Scleroderma Clinical Trials Consortium Damage Index working group. She is Medical Director of Arthritis Australia and Chair of the Actelion Clinical Excellence Program.
| Date | Position | Institution name |
|---|---|---|
| 2016 - ongoing | Head of Unit | Royal Adelaide Hospital, Adelaide |
| 2012 - 2014 | Clinical lead | Central Adelaide Local Health Network |
| 2011 - ongoing | Clinical Associate Professor | University of Adelaide |
| 2011 - 2015 | Research Scientist - Grade 5 | Royal Adelaide Hospital, Adelaide |
| 1998 - ongoing | Senior Staff Specialist, Rheumatology | Royal Adelaide Hospital |
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2014 | Award | Taverner Award for best presentation | - | - | - |
| 2013 | Award | State ARA award for best clinical presentation | - | - | - |
| 2012 | Award | Award for Best Clinical Paper | - | - | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 1994 | Royal Australasian College of Physicians, Sydney | Australia | Fellow |
| 1990 | Royal Australasian College of Physicians, Sydney | Australia | Part I; Fellowship Examination |
| University of Adelaide | Australia | MBBS (Hons) |
| Date | Title | Institution name | Country |
|---|---|---|---|
| 2014 | Fellow | Royal Australasian College of Physicians | - |
| Year | Citation |
|---|---|
| 2026 | Fraser, L., Wiese, M. D., Ailabouni, N., Ellett, L. K., Sirois, C., Berthelot, W., . . . Reeve, E. (2026). Patients’ attitudes towards deprescribing disease modifying anti-rheumatic drugs in rheumatoid arthritis. Patient Education and Counseling, 143(109432), 109432. |
| 2025 | Andréasson, K., Young, A., Joshi, S., Labus, J. S., Low, A. H. L., Smith, V., . . . Volkmann, E. R. (2025). International Investigation of the Gut-Lung Axis in Systemic Sclerosis–Interstitial Lung Disease. Arthritis Care and Research, 10 pages. Scopus2 WoS2 Europe PMC1 |
| 2025 | Nassar, E. L., Wurz, A., Carrier, M. E., Golberg, M., Adams, C., Kwakkenbos, L., . . . Hébert, M. (2025). Protocol for a two-arm parallel randomized controlled trial to evaluate patient and researcher co-presentation of research results: the Scleroderma Patient-centered Intervention Network—Patients Alongside Investigators in Research-Sharing (SPIN-PAIRS) trial. Trials, 26(1), 493. |
| 2025 | Dal Santo, C., Golberg, M., Carrier, M. E., Harel, D., Kwakkenbos, L., Bartlett, S. J., . . . Wilcox, P. (2025). Evaluation of the Coping Strategies Questionnaire-Revised for fatigue in systemic sclerosis: a Scleroderma Patient-centred Intervention Network (SPIN) cohort study. Clinical and Experimental Rheumatology, 43(8), 1455-1464. |
| 2025 | Rosa-Baez, C., Rangel-Pelaez, C., Rodriguez-Martin, I., Kerick, M., Guillen-Del-Castillo, A., Simeon-Aznar, C. P., . . . Acosta-Herrera, M. (2025). Assessing the MUC5B promoter variant in a large cohort of systemic sclerosis-associated interstitial lung disease. Rmd Open, 11(3), 6 pages. |
| 2025 | Egberts, B. K., Ananthakrishna, R., Shah, R., So, A. C. F., Walker, J., Pasupathy, S., . . . Selvanayagam, J. B. (2025). Characterization of the Left Ventricular Myocardium in Systemic Sclerosis. Journal of Clinical Medicine, 14(16), 5627. |
| 2025 | Fairley, J. L., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. S., Walker, J., . . . Ross, L. (2025). Clinical associations of worsening physical function as measured by HAQ-DI scores in systemic sclerosis. Journal of Scleroderma and Related Disorders, 10(3), 545-555. |
| 2025 | Fraser, L., Ailabouni, N., Ellett, L. K., Tan, J. M., Freeman, A., Proudman, S. M., . . . Wiese, M. D. (2025). A scoping review of disease-modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice. British Journal of Clinical Pharmacology, online(12), 1-11. Europe PMC1 |
| 2025 | Morrisroe, K., Hansen, D., Stevens, W., Ross, L., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2025). The prognostic importance of worsening dyspnoea in systemic sclerosis related interstitial lung disease. Seminars in Arthritis and Rheumatism, 75, 152826-1-152826-11. |
| 2025 | Ross, L., Lin, L., Hansen, D., Quinlivan, A., Stevens, W., Proudman, S., . . . Basnayake, C. (2025). Prevalence, clinical characteristics, and hospital course of systemic sclerosis-associated pseudo-obstruction. Clinical Rheumatology, 44(11), 4541-4551. |
| 2025 | Khoo, T., & Proudman, S. (2025). Does the Doctor's Sex Matter? Long-term Outcomes in Rheumatoid Arthritis Revisited. Mayo Clinic Proceedings, 100(10), 1687-1689. |
| 2025 | Tan, J. M., Desforges, K., Chai, W. C., Proudman, S. M., Wiese, M. D., & Reeve, E. (2025). Perspectives of patients with rheumatoid arthritis towards the use of parenteral methotrexate: a qualitative study. International Journal Of Clinical Pharmacy, online, 1-12. Europe PMC1 |
| 2025 | Lim, L., Hansen, D., Fairley, J., Tabesh, M., Ross, L., Ferdowsi, N., . . . Nikpour, M. (2025). Impact of Comorbidities on Treatments and Outcomes of Systemic Sclerosis–Associated Pulmonary Arterial Hypertension. Canadian Respiratory Journal, 2025(1), 9 pages. |
| 2025 | Martínez-López, J., Rangel-Peláez, C., Rodriguez-Martin, I., Guillen-Del-Castillo, A., Simeón-Aznar, C. P., Callejas, J. L., . . . Kerick, M. (2025). Distinct effects of complement C4A and C4B copy number in Systemic Sclerosis serological and clinical subtypes.. Arthritis & rheumatology (Hoboken, N.J.). |
| 2025 | Khanna, D., de Vries-Bouwstra, J., Hoffmann-Vold, A. M., Kuwana, M., Low, A. H. L., Proudman, S., . . . Distler, O. (2025). A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: Study design and rationale of the VITALISScE™ study. Journal of Scleroderma and Related Disorders, 10(1), 27-35. |
| 2025 | Ross, L., Hansen, D., Proudman, S., Walker, J., Kumar, K., Stevens, W., . . . Nikpour, M. (2025). Comparison of Three Physician Global Assessment Instruments in Systemic Sclerosis. Arthritis Care and Research, 77(2), 251-256. Scopus1 WoS1 Europe PMC1 |
| 2025 | Denton, C. P., Kowal-Bielecka, O., Proudman, S. M., Olesińska, M., Worm, M., Del Papa, N., . . . Gasior, M. J. (2025). A phase 2 randomized trial of safety and pharmacokinetics of IgPro20 and IgPro10 in patients with diffuse cutaneous systemic sclerosis. Rheumatology, 64(6), 3657-3666. |
| 2025 | Bennett, H., Mezzini, A., Proudman, S., Griggs, K., & Davison, K. (2025). Evaluation of progressive blood flow restricted resistance training and exercise preferences in individuals with rheumatoid arthritis. Disability And Rehabilitation, online(21), 1-12. |
| 2025 | Xu, M., Harel, D., Carrier, M. E., Kwakkenbos, L., Bartlett, S. J., Gottesman, K., . . . Nordlund, J. (2025). Differential Item Functioning on the Cochin Hand Function Scale Among People With Systemic Sclerosis by Language, Sex, and Disease Subtype: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort Study. Arthritis Care and Research, 77(3), 393-401. |
| 2025 | Baron, M., Hansen, D., Proudman, S., Stevens, W., Wang, M., & Nikpour, M. (2025). The minimal clinically important difference of the scleroderma clinical trials consortium damage index. Journal of Scleroderma and Related Disorders, 10(3), 285-292. |
| 2025 | Bryant, M. J., Lester, S., Russell, O., Whittle, S., Limaye, V., Proudman, S., . . . Hill, C. L. (2025). Implementation of a novel patient reported experience measure (PREM) in rheumatology: a cross-sectional online survey of Australian rheumatology outpatients. Rheumatology International, 45(6), 10 pages. Scopus1 WoS1 Europe PMC1 |
| 2025 | Kwakkenbos, L., Levis, B., Henry, R. S., Virgili-Gervais, G., Carrier, M. E., Bartlett, S. J., . . . Smets, P. (2025). Fatigue levels and associated factors in systemic sclerosis: a cross-sectional study of 2385 SPIN Cohort participants. Rheumatology, 64(5), 2810-2820. Scopus2 Europe PMC1 |
| 2025 | Fairley, J. L., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. S., Apostolopoulos, D., . . . Nikpour, M. (2025). Frequency and determinants of use of immunosuppressants in the Australian Scleroderma Cohort Study. Journal of Scleroderma and Related Disorders, 10(3), 1-11. |
| 2025 | Sukkar, M. B., Ainley, R., Barrett, C., Bond, S., Bradbury, L. A., Briggs, A. M., . . . Hill, C. L. (2025). Development of the Australian Rheumatology Association Clinical Care Standard for the diagnosis and management of rheumatoid arthritis in adults. Journal of Rheumatology, 52(9), 883-892. |
| 2025 | Zheng, B., Nikpour, M., Stevens, W., Proudman, S., Morrisroe, K., Wang, M., . . . Baron, M. (2025). Predicting trajectories of lung function decline in systemic sclerosis–related interstitial lung disease. Rheumatology, 64(11), 5892-5898. Scopus1 WoS1 |
| 2025 | Bird, A., Oakden-Rayner, L., Chakradeo, K., Thomas, R., Gupta, D., Jain, S., . . . Palmer, L. J. (2025). AI automated radiographic scoring in rheumatoid arthritis: Shedding light on barriers to implementation through comprehensive evaluation. Seminars in Arthritis and Rheumatism, 74, 152761. Scopus2 WoS1 |
| 2025 | Egberts, B. K., Perry, R., Stevens, W., Prior, D., Woodman, R., Pasupathy, S., . . . Selvanayagam, J. B. (2025). Utility of Right Ventricular Free Wall Systolic Strain for Prediction of Systemic Sclerosis associated Pulmonary Arterial Hypertension.. Eur Heart J Cardiovasc Imaging, 26(8), 1487-1489. Scopus1 WoS1 |
| 2025 | Thombs, B. D., Adams, C., Nassar, E. L., Carrier, M. E., Golberg, M., Bharthi, K., . . . Gyger, G. (2025). Master protocol for a series of cohort-based randomized controlled trials to test tools to communicate research results to study participants and others with relevant lived experience: the SPIN-CLEAR Trials. Trials, 26(1), 149. Scopus1 Europe PMC1 |
| 2025 | Fairley, J. L., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. S., Apostolopoulos, D., . . . Ross, L. (2025). The Prognostic and Functional Impact of Multimorbidity in Systemic Sclerosis. ACR Open Rheumatology, 7(4), e70034-1-e70034-9. Scopus1 WoS1 Europe PMC1 |
| 2024 | Fairley, J. L., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. -S., Apostolopoulos, D., . . . Ross, L. (2024). The frequency and clinical associations of opioid use in systemic sclerosis. Rheumatology Advances in Practice, 8(4), rkae144-1-rkae144-6. Scopus1 WoS1 Europe PMC1 |
| 2024 | Fairley, J. L., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. -S., Walker, J., . . . Ross, L. (2024). Progression and clinical implications of frailty in patients with systemic sclerosis. Clinical Rheumatology, 44(1), 305-317. Scopus2 WoS2 Europe PMC1 |
| 2024 | Virgili-Gervais, G., Matthews, B., Nassar, E. L., Carrier, M. E., Kwakkenbos, L., Pauling, J. D., . . . Robinson, D. (2024). The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study. Lancet Rheumatology, 6(10), e684-e692. Scopus3 |
| 2024 | Baron, M., Nikpour, M., Hansen, D., Proudman, S., Stevens, W., Australian Scleroderma Interest Group (ASIG) and the Canadian Scleroderma Research Group (CSRG)., & Wang, M. (2024). Immunosuppressive Drugs in Early Systemic Sclerosis and Prevention of Damage Accrual. Arthritis Care and Research, 77(5), 640-648. |
| 2024 | Shah, R. C., Morrisroe, K., Stevens, W., Ferdowsi, N., Proudman, S., Nikpour, M., & Ross, L. J. (2024). Scleroderma renal crisis, an increasingly rare but persistently challenging condition: a retrospective cohort study. Rheumatology Advances in Practice, 8(4), 7 pages. Scopus2 WoS2 Europe PMC1 |
| 2024 | Hong, L. E., Wechalekar, M. D., Kutyna, M. M., Small, A., Lim, K., Thompson-Peach, C. A., . . . Hiwase, D. K. (2024). IDH-Mutant Myeloid Neoplasms are Associated with Seronegative Rheumatoid Arthritis and Innate Immune Activation. Blood, 143(18), 1873-1877. Scopus11 WoS11 Europe PMC10 |
| 2024 | Morrisroe, K., Hansen, D., Stevens, W., Ross, L., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2024). Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis. Rheumatology, 64(SI), keae166. WoS1 Europe PMC1 |
| 2024 | Ross, L., McDonald, J., Hansen, D., Fairley, J., Wicks, C., Proudman, S., . . . Nikpour, M. (2024). Quantifying the need for specialist palliative care management in Patients with systemic sclerosis. Arthritis Care and Research, 76(7), 964-972. Scopus6 WoS8 Europe PMC6 |
| 2024 | Bird, A., Oakden-Rayner, L., Smith, L. A., Zeng, M., Ray, S., Proudman, S., & Palmer, L. J. (2024). Prognostic modeling in early rheumatoid arthritis: reconsidering the predictive role of disease activity scores.. Clin Rheumatol, 43(5), 1503-1512. |
| 2024 | Gregory, K., Hansen, D., Penglase, R., Apostolopoulos, D., Ngian, G. -S., Stevens, W., . . . Sahhar, J. (2024). Outcomes of patients with diffuse systemic sclerosis eligible for autologous stem cell transplantation managed with conventional therapy.. Arthritis & rheumatology (Hoboken, N.J.), 76(8), 1294-1302. Scopus7 WoS7 Europe PMC5 |
| 2024 | Fairley, J. L., Hansen, D., Quinlivan, A., Proudman, S., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2024). Frequency and implications of malnutrition in systemic sclerosis. Rheumatology, 64(3), 1251-1260. Scopus12 WoS12 Europe PMC6 |
| 2024 | Brown, Z., Hansen, D., Stevens, W., Ferdowsi, N., Ross, L., Quinlivan, A., . . . Nikpour, M. (2024). Evaluation of the European Society of Cardiology Risk Assessment Score in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. Arthritis Care and Research, 76(7), 973-983. Scopus3 WoS2 Europe PMC1 |
| 2024 | Fairley, J. L., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. S., Walker, J., . . . Ross, L. (2024). Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis. Seminars in Arthritis and Rheumatism, 66, 152443-1-152443-8. Scopus12 WoS12 Europe PMC9 |
| 2024 | Quinlivan, A., Neuen, D., Hansen, D., Stevens, W., Ross, L., Ferdowsi, N., . . . Nikpour, M. (2024). The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes. Arthritis Research and Therapy, 26(1), 124-1-124-8. Scopus2 WoS2 Europe PMC1 |
| 2024 | Ross, L., Hansen, D., Proudman, S., Khanna, D., Herrick, A. L., Stevens, W., . . . Valentini, G. (2024). Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index. Arthritis and Rheumatology, 76(11), 1635-1644. Scopus4 WoS5 Europe PMC4 |
| 2024 | Tan, J. M., Upton, R. N., Foster, D. J. R., Proudman, S. M., Dhir, V., & Wiese, M. D. (2024). Pharmacokinetic-pharmacodynamic modelling and simulation of methotrexate dosing in patients with rheumatoid arthritis. British Journal of Clinical Pharmacology, 90(11), 1-18. Scopus2 WoS2 Europe PMC1 |
| 2024 | Robinson, L., Hamden, M., Griggs, K., Simon, S., Hill, C., Limaye, V., & Proudman, S. (2024). Tocilizumab use in giant cell arteritis: comparing Pharmaceutical Benefits Scheme eligible and ineligible cases in South Australia. Internal Medicine Journal, 54(7), 1228-1232. |
| 2024 | Singh, M., Smitham, P., Jain, S., Day, C., Nijman, T., George, D., . . . Nimon, G. (2024). Exploring the viability of Virtual Reality as a teaching method for knee aspiration. Virtual Reality, 28(3), 10 pages. Scopus1 |
| 2024 | Wechalekar, M. D., Zhao, L. -P., Kutyna, M. M., Hong, L. E., Li, J., Hung, K., . . . Hiwase, D. K. (2024). Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features. Blood Cancer Journal, 14(1), 116-1-116-5. Scopus1 WoS1 Europe PMC1 |
| 2024 | Nassar, E. L., Virgili-Gervais, G., Carrier, M. E., Kwakkenbos, L., Henry, R. S., Hu, S., . . . Rodríguez Almazar, E. (2024). Experiences of telehealth during and after the COVID-19 pandemic and preferences for future care of people with systemic sclerosis: a cross-sectional study. Lancet Rheumatology, 6(10), e660-e663. Scopus1 |
| 2024 | Flurey, C. A., Jones, B., Gazel, U., Uzoka, C., Rosser, K., Khoo, T., . . . Proudman, S. (2024). “It means almost forgetting that you've got a disease”: An OMERACT study to define independence in the context of rheumatoid arthritis remission from the patient perspective. Seminars in Arthritis and Rheumatism, 68, 7 pages. |
| 2024 | Samm, D. -A., Macoustra, A., Crane, R., McWilliams, L., Proudman, S., & Chapple, L. -A. S. (2024). Views of nutrition needs in patients with systemic sclerosis. Journal of Scleroderma and Related Disorders, 9(3), 216-222. Europe PMC1 |
| 2024 | Brown, Z., Morrisroe, K., Hansen, D., Stevens, W., Proudman, S., Teng, G. G., . . . Nikpour, M. (2024). Predictive accuracy of the ASIG algorithm in a prospective systemic sclerosis cohort undergoing annual screening for pulmonary arterial hypertension. Internal Medicine Journal, 54(9), 1561-1566. Scopus1 WoS1 Europe PMC1 |
| 2024 | Fairley, J. L., Hansen, D., Proudman, S., Baron, M., Sahhar, J., Ngian, G. S., . . . Nikpour, M. (2024). The burden and determinants of fatigue in incident and prevalent systemic sclerosis. Clinical and Experimental Rheumatology, 42(8), 1669-1674. Scopus3 Europe PMC1 |
| 2024 | Fairley, J. L., Hansen, D., Baron, M., Proudman, S., Sahhar, J., Ngian, G. S., . . . Ross, L. (2024). Investigating the trajectory of functional disability in systemic sclerosis: group-based trajectory modelling of the Health Assessment Questionnaire-Disability Index. Clinical and Experimental Rheumatology, 42(8), 1581-1589. Scopus5 WoS6 Europe PMC5 |
| 2024 | Alkan, A., Carrier, M. E., Henry, R. S., Kwakkenbos, L., Bartlett, S. J., Gietzen, A., . . . Roux, S. (2024). Minimal Detectable Changes of the Health Assessment Questionnaire–Disability Index, Patient-Reported Outcomes Measurement Information System-29 Profile Version 2.0 Domains, and Patient Health Questionnaire-8 in People With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Cross-Sectional Study. Arthritis Care and Research, 76(11), 1549-1557. Scopus1 Europe PMC1 |
| 2024 | Taylor, L., Hansen, D., Morrisroe, K., Fairley, J., Calderone, A., Oon, S., . . . Nikpour, M. (2024). The impact of season, environmental temperature and humidity on Raynaud phenomenon in an Australian systemic sclerosis cohort. Arthritis Care and Research, 77(1), 61-68. Scopus2 WoS3 Europe PMC2 |
| 2024 | Rapoport, C. S., Choi, A. K., Kwakkenbos, L., Carrier, M. E., Henry, R. S., Levis, B., . . . Malcarne, V. L. (2024). Moderators of Loneliness Trajectories in People with Systemic Sclerosis During the COVID-19 Pandemic: A SPIN COVID-19 Cohort Longitudinal Study. International Journal of Behavioral Medicine, 31(3), 352-362. Scopus1 |
| 2024 | Maher, D., Reeve, E., Hopkins, A., Tan, J. M., Tantiongco, M., Ailabouni, N., . . . Wiese, M. (2024). Comparative Risk of Gout Flares When Initiating or Escalating Various Urate-Lowering Therapy: A Systematic Review With Network Meta-Analysis. Arthritis Care and Research, 76(6), 871-881. Scopus7 WoS7 Europe PMC2 |
| 2024 | Schwender, E., Hansen, D., Stevens, W., Ross, L., Proudman, S., Walker, J., . . . Morrisroe, K. (2024). Inflammatory arthritis in Systemic Sclerosis: its epidemiology, associations, and morbidity. Arthritis Care and Research, 76(6), 760-767. Scopus3 WoS3 Europe PMC2 |
| 2024 | Chapman, L. S., Alcacer-Pitarch, B., Pauling, J. D., Flurey, C. A., Redmond, A. C., Richards, P., . . . Siddle, H. J. (2024). Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group. Seminars in Arthritis and Rheumatism, 65, 6 pages. Scopus3 WoS3 Europe PMC3 |
| 2024 | Fairley, J. L., Hansen, D., Day, J., Proudman, S., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2024). Proximal weakness and creatine kinase elevation in systemic sclerosis: Clinical correlates, prognosis and functional implications. Seminars in Arthritis and Rheumatism, 65, 152363-1-152363-7. Scopus8 WoS8 Europe PMC8 |
| 2024 | Abbot, S., Proudman, S., Bednarz, J., & Williams, N. (2024). Outcomes of proximal humerus fractures in children: a retrospective cohort study.. ANZ journal of surgery, 94(4), 743-748. Europe PMC1 |
| 2024 | Parker, M. J. S., Jee, A. S., Hansen, D., Proudman, S., Youssef, P., Kenna, T. J., . . . Corte, T. J. (2024). Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis. Rheumatology, 63(11), 2981-2988. Scopus10 WoS12 Europe PMC9 |
| 2024 | Callisto, A., Hansen, D., Walker, J., Ngian, G. S., Apostolopoulos, D., Liew, D., . . . Proudman, S. (2024). Impact of the COVID-19 Pandemic on Health Care Access and Diagnosis of Pulmonary Arterial Hypertension Among Patients With Systemic Sclerosis. Arthritis Care and Research, 76(1), 81-87. Scopus2 WoS2 Europe PMC3 |
| 2023 | Morrisroe, K., Hansen, D., Stevens, W., Ross, L., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2023). Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease. RHEUMATOLOGY, 63(7), 1-8. Scopus11 WoS10 Europe PMC6 |
| 2023 | Ross, L., Hansen, D., Maltez, N., Morrisroe, K., Kumar, K., Walker, J., . . . Proudman, S. (2023). The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort study. Clinical Rheumatology, 43(1), 269-276. Scopus8 WoS9 Europe PMC6 |
| 2023 | Baron, M., Barbacki, A., Man, A., De Vries-Bouwstra, J. K., Johnson, D., Stevens, W., . . . Nikpour, M. (2023). Prediction of damage trajectories in systemic sclerosis using group-based trajectory modelling. Rheumatology United Kingdom, 62(9), 3059-3066. Scopus5 WoS5 Europe PMC3 |
| 2023 | Khoo, T., Jones, B., Chin, A., Terrett, A., Voshaar, M., Hoogland, W., . . . Proudman, S. (2023). Defining independence: A scoping review by the OMERACT patient perspective of remission in rheumatoid arthritis group. Seminars in Arthritis and Rheumatism, 58, 8 pages. Scopus4 WoS3 Europe PMC2 |
| 2023 | Samm, D. -A. A., Macoustra, A. R., Crane, R. K., McWilliams, L. M., Proudman, S. M., & Chapple, L. -A. S. (2023). A survey of Australian rheumatologists’ perspectives of nutrition needs in systemic sclerosis. Journal of Scleroderma and Related Disorders, 8(3), 203-209. Scopus1 WoS1 Europe PMC1 |
| 2023 | Wojeck, R. K., Knisely, M. R., Bailey, D. E., Somers, T. J., Kwakkenbos, L., Carrier, M. E., . . . Varga, J. (2023). Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional study. Eclinicalmedicine, 62, 102104. Scopus3 |
| 2023 | Tan, J. M., Reeve, E., Fraser, L., Proudman, S. M., & Wiese, M. D. (2023). The Barriers and Enablers to the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review. Arthritis Care and Research, 75(11), 2306-2315. Scopus2 WoS2 Europe PMC2 |
| 2023 | S. Rapoport, C., Choi, A. K., Kwakkenbos, L., Carrier, M. E., Henry, R. S., Mouthon, L., . . . Malcarne, V. L. (2023). Evaluation of Measurement Properties and Differential Item Functioning in the English and French Versions of the University of California, Los Angeles, Loneliness Scale-6: A Scleroderma Patient-Centered Intervention Network (SPIN) Study. Arthritis Care and Research, 75(10), 2158-2165. Scopus3 Europe PMC2 |
| 2023 | Fairley, J. L., Hansen, D., Ross, L., Proudman, S., Sahhar, J., Ngian, G. -S., . . . Australian Scleroderma Interest Group. (2023). Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.. Arthritis Research and Therapy, 25(1), 1-13. Scopus15 WoS14 Europe PMC9 |
| 2023 | Maltez, N., Hughes, M., Brown, E., Hickey, V., Shea, B., Herrick, A. L., . . . Pauling, J. D. (2023). Domain reporting in systemic sclerosis-related Raynaud's phenomenon: An OMERACT scoping review.. Seminars in arthritis and rheumatism, 61, 1-6. Scopus8 WoS6 Europe PMC5 |
| 2023 | Hughes, M., Maltez, N., Brown, E., Hickey, V., Shea, B., Pauling, J. D., . . . Herrick, A. L. (2023). Domain reporting in Systemic Sclerosis-Related Digital Ulcers: An OMERACT Scoping Review. Seminars in Arthritis and Rheumatism, 61, 1-6. Scopus3 WoS4 Europe PMC4 |
| 2023 | Spiera, R., Kuwana, M., Khanna, D., Hummers, L., Frech, T. M., Stevens, W., . . . Denton, C. P. (2023). Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis. Arthritis and Rheumatology, 75(9), 1608-1618. Scopus33 Europe PMC27 |
| 2023 | Neyer, M. A., Henry, R. S., Carrier, M. E., Kwakkenbos, L., Wojeck, R. K., Gietzen, A., . . . Thombs, B. D. (2023). Validity, Reliability, and Differential Item Functioning of English and French Versions of the 10-Item Connor-Davidson Resilience Scale in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study. Arthritis Care and Research, 75(11), 2369-2378. Scopus11 Europe PMC10 |
| 2023 | Barbacki, A., Baron, M., Wang, M., Zhang, Y., Stevens, W., Sahhar, J., . . . Australian Scleroderma Interest Group and the Canadian Scleroderma Research Group. (2023). Damage Trajectories in Systemic Sclerosis Using Group-Based Trajectory Modeling. Arthritis Care and Research, 75(3), 640-647. Scopus13 WoS12 Europe PMC9 |
| 2023 | Lowe, K., Small, A., Song, Q., Hao, L. -Y., Murray-Brown, W., Proudman, S., . . . Wechalekar, M. D. (2023). Transcriptomic profiling of programmed cell death 1 (PD-1) expressing T cells in early rheumatoid arthritis identifies a decreased CD4 + PD-1 + signature post-treatment.. Scientific Reports, 13(1), 2847. Scopus9 WoS11 Europe PMC6 |
| 2023 | Jee, A. S., Stewart, I., Youssef, P., Adelstein, S., Lai, D., Hua, S., . . . Nguyen, M. A. (2023). A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis–Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study. Arthritis and Rheumatology, 75(8), 1424-1433. Scopus18 WoS17 Europe PMC15 |
| 2023 | Black, R. J., Lester, S., Tieu, J., Sinnathurai, P., Barrett, C., Buchbinder, R., . . . Hill, C. L. (2023). Mortality estimates and excess mortality in rheumatoid arthritis. Rheumatology, 62(11), 3576-3583. Scopus37 WoS37 Europe PMC27 |
| 2023 | Smith, R., Harrison, M., Lam, K. -V., Adler, B., Bulsara, M., Sahhar, J., . . . Gabbay, E. (2023). The emerging association between bronchiectasis and systemic sclerosis: assessing prevalence and potential causality. Internal Medicine Journal, 53(7), 1204-1211. Scopus4 WoS5 Europe PMC2 |
| 2022 | Galindo Feria, A. S., Horuluoglu, B., Day, J., Fernandes Cerqueira, C., Wigren, E., Graslund, S., . . . Limaye, V. (2022). Autoantibodies against four-and-a-half-LIM domain 1 (FHL1) in inflammatory myopathies: results from an Australian single-centre cohort. Rheumatology, 61(10), 4145-4154. Scopus11 WoS11 Europe PMC10 |
| 2022 | Zheng, B., Wang, M., Stevens, W., Proudman, S., Nikpour, M., & Baron, M. (2022). Associations between the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis (CRISS), survival and other disease measures. Seminars in Arthritis and Rheumatism, 53, 6 pages. Scopus5 WoS5 Europe PMC5 |
| 2022 | Valenzuela, A., Stevens, K., Chung, M. P., Rodriguez-Reyna, T. S., Proudman, S., Baron, M., . . . Chung, L. (2022). Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis. Seminars in Arthritis and Rheumatism, 53, 7 pages. Scopus11 WoS11 Europe PMC11 |
| 2022 | Pisaniello, H. L., Whittle, S. L., Lester, S., Menz, F., Metcalf, R., McWilliams, L., . . . Proudman, S. (2022). Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis. BMC Rheumatology, 6(1), 11 pages. Scopus13 WoS13 Europe PMC12 |
| 2022 | Ross, L., Proudman, S., Walker, J., Stevens, W., Ferdowsi, N., Quinlivan, A., . . . Nikpour, M. (2022). Evaluation of patient and physician assessments of gastrointestinal disease activity in systemic sclerosis. The Journal of Rheumatology, 50(4), 519-525. Scopus6 WoS6 Europe PMC4 |
| 2022 | Bird, A., Oakden-Rayner, L., McMaster, C., Smith, L. A., Zeng, M., Wechalekar, M. D., . . . Palmer, L. J. (2022). Artificial intelligence and the future of radiographic scoring in rheumatoid arthritis: a viewpoint. Arthritis Research & Therapy, 24(1), 1-10. Scopus26 WoS23 Europe PMC14 |
| 2022 | Kerick, M., Acosta-Herrera, M., Simeón-Aznar, C. P., Callejas, J. L., Assassi, S., Carreira, P., . . . Ortega-Castro, R. (2022). Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. Npj Genomic Medicine, 7(1), 12 pages. Scopus10 WoS10 Europe PMC9 |
| 2022 | Murray-Brown, W., Guo, Y., Small, A., Lowe, K., Weedon, H., Smith, M. D., . . . Wechalekar, M. D. (2022). Differential expansion of T peripheral helper cells in early rheumatoid arthritis and osteoarthritis synovium. RMD open, 8(2), 1-7. Scopus21 WoS21 Europe PMC14 |
| 2022 | Tsakas, J. J., Liew, D. F. L., Adams, C. L., Hill, C. L., Proudman, S., Whittle, S., . . . Robinson, P. C. (2022). Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees. BMC Rheumatology, 6(1), 59-1-59-8. Scopus2 WoS2 Europe PMC1 |
| 2022 | Scofield, R. H., Lewis, V. M., Cavitt, J., Kurien, B. T., Assassi, S., Martin, J., . . . Miller, F. W. (2022). 47XXY and 47XXX in Scleroderma and Myositis. Acr Open Rheumatology, 4(6), 528-533. Scopus19 WoS18 Europe PMC15 |
| 2022 | Kwakkenbos, L., Østbø, N., Carrier, M. E., Nielson, W. R., Fedoruk, C., Levis, B., . . . Sobanski, V. (2022). Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program. Pilot and Feasibility Studies, 8(1). Scopus5 |
| 2022 | Morrisroe, K., Hansen, D., Stevens, W., Sahhar, J., Ngian, G. S., Hill, C., . . . Nikpour, M. (2022). Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival. Arthritis Research and Therapy, 24(1), 10 pages. Scopus13 WoS14 Europe PMC14 |
| 2022 | Hanson, A. L., Sahhar, J., Ngian, G. -S., Roddy, J., Walker, J., Stevens, W., . . . Brown, M. A. (2022). Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes. Frontiers in Genetics, 13, 913196-1-913196-13. Scopus14 WoS13 Europe PMC11 |
| 2022 | Daraghmeh, D. N., Hopkins, A. M., King, C., Abuhelwa, A. Y., Wechalekar, M. D., Proudman, S. M., . . . Wiese, M. D. (2022). Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs. Rheumatology (Oxford, England), 62(2), 583-595. Scopus7 WoS4 Europe PMC3 |
| 2022 | Daraghmeh, D. N., Moghaddami, M., Bobrovskaya, L., Proudman, S. M., & Wiese, M. D. (2022). Quantitation of methotrexate polyglutamates in human whole blood, erythrocytes and leukocytes collected via venepuncture and volumetric absorptive micro-sampling: a green LC-MS/MS-based method. Analytical And Bioanalytical Chemistry, 414(20), 6029-6046. Scopus19 WoS19 Europe PMC13 |
| 2022 | Manning Bennett, A. T., Hopkins, A. M., Sorich, M. J., Proudman, S. M., Foster, D. J. R., Abuhelwa, A. Y., & Wiese, M. D. (2022). The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis - a pooled analysis of five randomised controlled trials. Therapeutic Advances in Musculoskeletal Disease, 14, 1-14. Scopus16 WoS15 Europe PMC15 |
| 2022 | Abbot, S., Proudman, S., Sim, Y. P., & Williams, N. (2022). Psychometric properties of patient-reported outcomes measures used to assess upper limb pathology: a systematic review.. ANZ Journal of Surgery, 92(12), 3170-3175. Scopus3 WoS5 Europe PMC5 |
| 2022 | Hughes, M., Allanore, Y., Baron, M., Del Galdo, F., Denton, C. P., Frech, T., . . . Matucci-Cerinic, M. (2022). Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease. Lancet Rheumatology, 4(11), e795-e803. Scopus14 WoS16 Europe PMC12 |
| 2022 | Abbot, S., Proudman, S., Ravichandran, B., & Williams, N. (2022). Predictors of outcomes of proximal humerus fractures in children and adolescents: A systematic review. Journal of Children's Orthopaedics, 16(5), 347-354. Scopus5 WoS4 Europe PMC4 |
| 2022 | Abbot, S. R., Proudman, S., Hall, K., & Williams, N. (2022). Outcomes of proximal humerus fractures in children: a study protocol for a retrospective cohort study.. BMJ Open, 12(9), e062586-1-e062586-7. Scopus3 WoS3 Europe PMC2 |
| 2022 | Villanueva-Martin, G., Acosta-Herrera, M., Kerick, M., López-Isac, E., Simeón, C. P., Callejas, J. L., . . . Bossini-Castillo, L. (2022). The Effect of Body Fat Distribution on Systemic Sclerosis. Journal of Clinical Medicine, 11(20), 6014. Scopus4 |
| 2022 | Kwakkenbos, L., Carrier, M. E., Welling, J., Levis, B., Levis, A. W., Sauve, M., . . . Roux, S. (2022). Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial. Trials, 23(1), 994. Scopus8 Europe PMC6 |
| 2021 | Bossini-Castillo, L., Villanueva-Martin, G., Kerick, M., Acosta-Herrera, M., López-Isac, E., Simeón, C. P., . . . Martin, J. (2021). Genomic Risk Score impact on susceptibility to systemic sclerosis. Annals of the Rheumatic Diseases, 80(1), 118-127. Scopus25 Europe PMC21 |
| 2021 | Nordlund, J., Henry, R. S., Kwakkenbos, L., Carrier, M. E., Levis, B., Nielson, W. R., . . . Proudman, S. (2021). The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial. Trials, 22(1), 856. Scopus8 Europe PMC6 |
| 2021 | Fairley, J., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. -S., Walker, J., . . . Nikpour, M. (2021). Clinical characteristics and survival in systemic sclerosis-mixed connective tissue disease and systemic sclerosis-overlap syndrome. Arthritis Care and Research, 73(5), 732-741. Scopus20 WoS20 Europe PMC15 |
| 2021 | Wu, Y., Kwakkenbos, L., Henry, R. S., Carrier, M. E., Gagarine, M., Harb, S., . . . Thombs, B. D. (2021). Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study. Journal of Psychosomatic Research, 140, 110314. Scopus12 Europe PMC6 |
| 2021 | Richard, N., Gyger, G., Hoa, S., Proudman, S., Stevens, W., Nikpour, M., . . . Canadian Scleroderma Research Group (CSRG), Australian Scleroderma Interest Group (ASIG). (2021). Immunosuppression does not prevent severe gastrointestinal tract involvement in systemic sclerosis.. Clinical and experimental rheumatology, 39(Suppl. 131), S-142-S-148. Scopus11 WoS10 Europe PMC10 |
| 2021 | Hoa, S., Bernatsky, S., Baron, M., Proudman, S., Stevens, W., Sahhar, J., . . . Zochling, J. (2021). Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis. Chest, 160(6), 2158-2162. Scopus9 WoS9 Europe PMC7 |
| 2021 | Adams, L., Lester, S., Hoon, E., van der Haak, H., Proudman, C., Hall, C., . . . Hill, C. L. (2021). Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID-19 pandemic in Australia.. Internal medicine journal, 51(7), 1028-1037. Scopus40 WoS39 Europe PMC36 |
| 2021 | Jones, B., Flurey, C. A., Proudman, S., Ferreira, R. J. O., Voshaar, M., Hoogland, W., . . . Boers, M. (2021). Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report. Seminars in Arthritis and Rheumatism, 51(5), 1108-1112. Scopus9 WoS8 Europe PMC6 |
| 2021 | Roofeh, D., Barratt, S. L., Wells, A. U., Kawano-Dourado, L., Tashkin, D., Strand, V., . . . Khanna, D. (2021). Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process. Seminars in Arthritis and Rheumatism, 51(6), 1331-1341. Scopus9 WoS8 Europe PMC4 |
| 2021 | Rasch, L., Boers, M., Lems, W., van Schaardenburg, D., Proudman, S., Hill, C. L., . . . van Tuyl, L. (2021). Patient perspective on remission in rheumatoid arthritis: Validation of patient reported outcome instruments to measure absence of disease activity. Seminars in Arthritis and Rheumatism, 51(6), 1360-1369. Scopus3 WoS2 Europe PMC3 |
| 2021 | Lee, Y. C., Fox, R. S., Kwakkenbos, L., Levis, B., Carrier, M. E., Welling, J., . . . Wilcox, P. (2021). Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study. Lancet Rheumatology, 3(12), e844-e854. Scopus19 |
| 2021 | Ghofrani, H. A., Gomez Sanchez, M. A., Humbert, M., Pittrow, D., Simonneau, G., Gall, H., . . . Schulz, C. (2021). Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry. Respiratory Medicine, 178, 106220. Scopus27 Europe PMC21 |
| 2021 | Proudman, S. M., & Corte, T. J. (2021). Are serum biomarkers useful in the management of systemic sclerosis-associated interstitial lung disease?. Respirology, 26(5), 406-408. |
| 2021 | Sree Raman, K., Shah, R., Stokes, M., Walls, A., Woodman, R. J., Perry, R., . . . Selvanayagam, J. B. (2021). Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension. Journal of Cardiovascular Magnetic Resonance, 23(1), 22-1-22-11. Scopus9 WoS8 Europe PMC5 |
| 2021 | Tran‐Duy, A., Morrisroe, K., Clarke, P., Stevens, W., Proudman, S., Sahhar, J., & Nikpour, M. (2021). Cost‐effectiveness of combination therapy for patients with systemic sclerosis–related pulmonary arterial hypertension. Journal of the American Heart Association, 10(7), e015816-1-e015816-[17]. Scopus8 WoS5 Europe PMC7 |
| 2021 | Brown, Z., Proudman, S., Morrisroe, K., Stevens, W., Hansen, D., & Nikpour, M. (2021). Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: a systematic review and meta-analysis of long-term outcomes. Seminars in Arthritis and Rheumatism, 51(3), 495-512. Scopus16 WoS16 Europe PMC14 |
| 2021 | Acosta-Herrera, M., Kerick, M., Lopéz-Isac, E., Assassi, S., Beretta, L., Simeón-Aznar, C. P., . . . Martin, J. (2021). Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes. Annals of the Rheumatic Diseases, 80(8), 1040-1047. Scopus31 WoS33 Europe PMC27 |
| 2021 | Lee, A., Patterson, K. A., Tan, D. J., Wilson, M. E., Proudman, S. M., Stevens, W., . . . Walker, J. G. (2021). Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients. Scandinavian Journal of Rheumatology, 50(6), 469-474. Scopus25 WoS26 Europe PMC21 |
| 2021 | Abuhelwa, A. Y., Foster, D. J. R., Manning Bennett, A., Sorich, M. J., Proudman, S., Wiese, M. D., & Hopkins, A. M. (2021). Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc multicohort analysis. Therapeutic Advances in Musculoskeletal Disease, 13, 1-7. Scopus2 WoS2 Europe PMC1 |
| 2021 | Maltez, N., Hughes, M., Brown, E., Hickey, V., Park, H., Shea, B., . . . Merkel, P. A. (2021). Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020. Seminars in Arthritis and Rheumatism, 51(3), 640-643. Scopus13 WoS11 Europe PMC6 |
| 2021 | Wiese, M. D., Hopkins, A. M., King, C., Wechalekar, M. D., Lee, A., Spargo, L., . . . Proudman, S. M. (2021). Precision medicine with leflunomide: consideration of DHODH haplotype and plasma teriflunomide concentration can substantially modify outcomes in patients with rheumatoid arthritis. Arthritis Care & Research, 73(7), 983-989. Scopus10 WoS7 Europe PMC6 |
| 2021 | Khadra, Y., Walker, J. G., Hakendorf, P., Proudman, S., Rischmueller, M., Hill, C. L., . . . Roberts-Thomson, P. J. (2021). Scleroderma renal crisis: observations from the South Australian Scleroderma Register. Internal Medicine Journal, 51(2), 235-242. Scopus4 WoS3 Europe PMC2 |
| 2020 | Ruediger, C., Nguyen, L., Black, R., Proudman, S., & Hill, C. (2020). Efficacy of Methotrexate in Polymyalgia Rheumatica in routine rheumatology clinical care.. Internal medicine journal, 50(9), 1067-1072. Scopus8 WoS6 Europe PMC6 |
| 2020 | Quinlivan, A., Ross, L., & Proudman, S. (2020). Systemic sclerosis: Advances towards stratified medicine.. Best practice & research. Clinical rheumatology, 34(1), 101469. Scopus11 WoS11 Europe PMC10 |
| 2020 | Morrisroe, K., Stevens, W., Sahhar, J., Ngian, G. -S., Ferdowsi, N., Hansen, D., . . . Nikpour, M. (2020). The clinical and economic burden of systemic sclerosis related interstitial lung disease.. Rheumatology (Oxford, England), 59(8), 1878-1888. Scopus31 WoS32 Europe PMC24 |
| 2020 | Day, J., Otto, S., Cash, K., Eldi, P., Hissaria, P., Proudman, S., . . . Hayball, J. D. (2020). Aberrant expression of high mobility group box protein 1 in the idiopathic inflammatory myopathies. Frontiers in Cell and Developmental Biology, 8(article no. 226 q 1), 11 pages. Scopus13 WoS14 Europe PMC14 |
| 2020 | Fortuné, C., Gietzen, A., Guillot, G., Lewis, N., Nielsen, K., Richard, M., . . . COVID-19 Patient Advisory Team. (2020). Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients.. Journal of psychosomatic research, 135, 11 pages. WoS25 |
| 2020 | Foers, A. D., Garnham, A. L., Smyth, G. K., Proudman, S. M., Cheng, L., Hill, A. F., . . . Wicks, I. P. (2020). Circulating small noncoding RNA biomarkers of response to triple disease-modifying antirheumatic drug therapy in white women with early rheumatoid arthritis. Journal of Rheumatology, 47(12), 1746-1751. Scopus6 WoS6 Europe PMC5 |
| 2020 | Murray-Brown, W., Wilsdon, T. D., Weedon, H., Proudman, S., Sukumaran, S., Klebe, S., . . . Wechalekar, M. D. (2020). Nivolumab-induced synovitis is characterized by florid T cell infiltration and rapid resolution with synovial biopsy-guided therapy. Journal for Immunotherapy of Cancer, 8(1), 6 pages. Scopus27 WoS27 Europe PMC22 |
| 2020 | Reid, A. B., Wiese, M., McWilliams, L., Metcalf, R., Hall, C., Lee, A., . . . Proudman, S. M. (2020). Repeat serological testing for anti-citrullinated peptide antibody after commencement of therapy is not helpful in patients with seronegative rheumatoid arthritis. Internal Medicine Journal, 50(7), 818-822. Scopus5 WoS5 Europe PMC3 |
| 2020 | Ross, L., Stevens, W., Wilson, M., Huq, M., Strickland, G., Walker, J., . . . Nikpour, M. (2020). Performance of the 2017 EUSTAR activity index in an scleroderma cohort. Clinical Rheumatology, 39(12), 3701-3705. Scopus9 WoS10 Europe PMC7 |
| 2020 | Brown, Z., Metcalf, R., Bednarz, J., Spargo, L., Lee, A., Hill, C., . . . Proudman, S. (2020). Modifiable Lifestyle Factors Associated With Response to Treatment in Early Rheumatoid Arthritis. Acr Open Rheumatology, 2(6), 371-377. Scopus8 WoS8 Europe PMC7 |
| 2020 | Proudman, S. (2020). Consensus statements for managing systemic sclerosis-associated interstitial lung disease. Lancet Rheumatology, 2(2), e64-e65. |
| 2020 | Anderson, J., Lavender, M., Lau, E., Celermajer, D., Collins, N., Dwyer, N., . . . Strange, G. (2020). Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges. Heart Lung and Circulation, 29(10), 1459-1468. Scopus3 WoS3 Europe PMC3 |
| 2020 | Ross, L., Stevens, W., Wilson, M., Strickland, G., Walker, J., Sahhar, J., . . . Nikpour, M. (2020). Can patient-reported symptoms be used to measure disease activity in systemic sclerosis?. Arthritis Care and Research, 72(10), 1459-1465. Scopus14 WoS14 Europe PMC13 |
| 2020 | Morrisroe, K., Hansen, D., Huq, M., Stevens, W., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2020). Incidence, risk factors and outcomes of cancer in systemic sclerosis. Arthritis Care and Research, 72(11), 1625-1635. Scopus51 WoS43 Europe PMC30 |
| 2020 | Abbot, S., McWilliams, L., Spargo, L., de Costa, C., Ur-Rehman, Z., Proudman, S., & Bossingham, D. (2020). Scleroderma in Cairns: an epidemiological study. Internal Medicine Journal, 50(4), 445-452. Scopus14 WoS14 Europe PMC12 |
| 2020 | Valenzuela, A., Baron, M., Rodriguez-Reyna, T. S., Proudman, S., Khanna, D., Young, A., . . . Chung, L. (2020). Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis.. Seminars in arthritis and rheumatism, 50(5), 891-896. Scopus42 WoS37 Europe PMC29 |
| 2020 | Patel, S., Morrisroe, K., Proudman, S., Hansen, D., Sahhar, J., Sim, M. R., . . . Australian Scleroderma Interest Group. (2020). Occupational silica exposure in an Australian systemic sclerosis cohort. Rheumatology, 59(12), 3900-3905. Scopus31 WoS29 Europe PMC27 |
| 2020 | Abuhelwa, A. Y., Hopkins, A. M., Sorich, M. J., Proudman, S., Foster, D. J. R., & Wiese, M. D. (2020). Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs. Scientific Reports, 10(18634), 1-9. Scopus29 WoS28 Europe PMC24 |
| 2020 | Raman, K. S., Shah, R., Stokes, M., Walls, A., Woodman, R. J., Ananthakrishna, R., . . . Selvanayagam, J. B. (2020). Left ventricular ischemia in pre-capillary pulmonary hypertension: a cardiovascular magnetic resonance study. Cardiovascular Diagnosis and Therapy, 10(5), 1280-1292. Scopus7 WoS8 Europe PMC6 |
| 2020 | Hong, L. E., Proudman, S., & Limaye, V. (2020). Interstitial pneumonia with autoimmune features in a patient with melanoma differentiation-associated gene 5 (MDA5) antibody. BMJ Case Reports, 13(11), 4 pages. Scopus2 WoS1 Europe PMC2 |
| 2020 | Thombs, B. D., Kwakkenbos, L., Henry, R. S., Carrier, M. -E., Patten, S., Harb, S., . . . Ellis, K. (2020). Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study. JOURNAL OF PSYCHOSOMATIC RESEARCH, 139, 10 pages. WoS32 Europe PMC26 |
| 2019 | Quinlivan, A., Proudman, S., Sahhar, J., Stevens, W., Nikpour, M., Major, G., . . . Youseff, P. (2019). Cost savings with a novel algorithm for early detection of systemic sclerosis-related pulmonary arterial hypertension: alternative scenario analyses. Internal Medicine Journal, 49(6), 781-785. Scopus6 WoS4 Europe PMC4 |
| 2019 | Boulos, D., Proudman, S. M., Metcalf, R. G., McWilliams, L., Hall, C., & Wicks, I. P. (2019). The neutrophil-lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapy. Seminars in Arthritis and Rheumatism, 49(3), 373-376. Scopus25 WoS25 Europe PMC19 |
| 2019 | Harel, D., Mills, S. D., Kwakkenbos, L., Carrier, M. -E., Nielsen, K., Portales, A., . . . Lambert, M. (2019). Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort. BMJ OPEN, 9(2), 10 pages. WoS15 Europe PMC11 |
| 2019 | Metwally, M., Thabet, K., Bayoumi, A., Nikpour, M., Stevens, W., Sahhar, J., . . . Eslam, M. (2019). IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis. Scientific Reports, 9(1), 14834. Scopus24 WoS19 Europe PMC16 |
| 2019 | Khoo, T., Stokes, M. B., Teo, K., Proudman, S., Basnayake, S., Sanders, P., & Limaye, V. (2019). Cardiac involvement in idiopathic inflammatory myopathies detected by cardiac magnetic resonance imaging. Clinical Rheumatology, 38(12), 3471-3476. Scopus27 WoS25 Europe PMC20 |
| 2019 | Maundrell, A., Proudman, S., & Limaye, V. (2019). Prevalence of other connective tissue diseases in idiopathic inflammatory myopathies. Rheumatology International, 39(10), 1777-1781. Scopus19 WoS19 Europe PMC16 |
| 2019 | Butler, E. A., Baron, M., Fogo, A. B., Frech, T., Ghossein, C., Hachulla, E., . . . Walker, U. A. (2019). Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology. Arthritis and Rheumatology, 71(6), 964-971. Scopus52 WoS46 Europe PMC38 |
| 2019 | Khoo, T., Proudman, S., & Limaye, V. (2019). Silicone breast implants and depression, fibromyalgia and chronic fatigue syndrome in a rheumatology clinic population. Clinical Rheumatology, 38(5), 1271-1276. Scopus27 WoS23 Europe PMC21 |
| 2019 | Wabe, N., Lee, A., Wechalekar, M., McWilliams, L., Proudman, S., & Wiese, M. (2019). Factors associated with medication adherence in a longitudinal study of rheumatoid arthritis patients. International Journal of Clinical Practice, 73(7), 9 pages. Scopus24 WoS27 Europe PMC16 |
| 2019 | Morrisroe, K., Stevens, W., Sahhar, J., Ngian, G. -S., Ferdowsi, N., Hansen, D., . . . Nikpour, M. (2019). The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia. BMC Pulmonary Medicine, 19(1), 226-1-226-11. Scopus8 WoS9 Europe PMC5 |
| 2019 | Morrisroe, K., Stevens, W., Sahhar, J., Ngian, G. -S., Ferdowsi, N., Hill, C. L., . . . Nikpour, M. (2019). Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden. Arthritis Research and Therapy, 21(1), 299-1-299-12. Scopus54 WoS52 Europe PMC37 |
| 2019 | López-Isac, E., Acosta-Herrera, M., Kerick, M., Assassi, S., Satpathy, A. T., Granja, J., . . . Chang, H. Y. (2019). GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nature Communications, 10(1), 14 pages. Scopus135 WoS131 Europe PMC130 |
| 2019 | Brown, Z., Metcalf, R., Bednarz, J., Stavrou, C., Spargo, L., James, M., & Proudman, S. (2019). Modifiable Factors Associated with Response to Treatment in Early Rheumatoid Arthritis. ARTHRITIS & RHEUMATOLOGY, 71, 3 pages. WoS1 |
| 2019 | Ross, L., Prior, D., Proudman, S., Vacca, A., Baron, M., & Nikpour, M. (2019). Defining primary systemic sclerosis heart involvement: a scoping literature review. Seminars in Arthritis and Rheumatism, 48(5), 874-887. Scopus45 WoS46 Europe PMC40 |
| 2019 | Moxey, J., Huq, M., Proudman, S., Sahhar, J., Ngian, G. S., Walker, J., . . . Nikpour, M. (2019). Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis. Arthritis Research and Therapy, 21(1), 57-1-57-12. Scopus31 WoS29 Europe PMC24 |
| 2019 | Richard, N., Hudson, M., Wang, M., Gyger, G., Proudman, S., Stevens, W., . . . Baron, M. (2019). Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality. Rheumatology, 58(4), 636-644. Scopus48 WoS54 Europe PMC34 |
| 2019 | McMahan, Z. H., Frech, T., Berrocal, V., Lim, D., Bruni, C., Matucci-Cerinic, M., . . . Khanna, D. (2019). Longitudinal assessment of patient-reported outcome measures in systemic sclerosis patients with gastroesophageal reflux disease - Scleroderma clinical trials consortium. Journal of Rheumatology, 46(1), 78-84. Scopus17 WoS16 Europe PMC15 |
| 2019 | Ferdowsi, N., Huq, M., Stevens, W., Hudson, M., Wang, M., Tay, T., . . . Nikpour, M. (2019). Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): A novel instrument to quantify organ damage in systemic sclerosis. Annals of the Rheumatic Diseases, 78(6), 807-816. Scopus55 WoS57 Europe PMC34 |
| 2018 | Abbot, S., Bossingham, D., Proudman, S., de Costa, C., & Ho-Huynh, A. (2018). Risk factors for the development of systemic sclerosis: A systematic review of the literature. Rheumatology Advances in Practice, 2(2), 1-12. Scopus29 WoS26 Europe PMC20 |
| 2018 | Massolino, R. I., Hissaria, P., Lee, A., & Proudman, S. M. (2018). Tocilizumab-induced drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient with rheumatoid arthritis. Rheumatology Advances in Practice, 2(2), 1-2. Scopus6 WoS4 Europe PMC4 |
| 2018 | Wilsdon, T. D., & Proudman, S. (2018). Early arthritis: A guide to assessment. Medicine Today, 19(11), 12-18. |
| 2018 | Morrisroe, K., Hudson, M., Baron, M., De Vries-Bouwstra, J., Carreira, P. E., Wuttge, D. M., . . . Nikpour, M. (2018). Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort. Clinical and Experimental Rheumatology, 36(Suppl. 113), S53-S60. Scopus26 WoS23 Europe PMC14 |
| 2018 | Ross, L., Stevens, W., Rabusa, C., Wilson, M., Ferdowsi, N., Walker, J., . . . Nikpour, M. (2018). The role of inflammatory markers in assessment of disease activity in systemic sclerosis. Clinical and Experimental Rheumatology, 36(suppl. 113 (4)), S126-S134. Scopus34 Europe PMC25 |
| 2018 | Thakkar, V., Patterson, K., Stevens, W., Wilson, M., Roddy, J., Sahhar, J., . . . Nikpour, M. (2018). Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations. Clinical Rheumatology, 37(6), 1563-1571. Scopus17 WoS17 Europe PMC12 |
| 2018 | Cole, S., Walsh, A., Yin, X., Wechalekar, M., Smith, M., Proudman, S., . . . Guo, Y. (2018). Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus. Arthritis Research and Therapy, 20(1), 14 pages. Scopus111 WoS99 Europe PMC92 |
| 2018 | Strange, G., Lau, E. M., Giannoulatou, E., Corrigan, C., Kotlyar, E., Kermeen, F., . . . Keogh, A. (2018). Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand. Heart Lung and Circulation, 27(11), 1368-1375. Scopus29 WoS27 Europe PMC21 |
| 2018 | Herrick, A. L., Peytrignet, S., Lunt, M., Pan, X., Hesselstrand, R., Mouthon, L., . . . Denton, C. P. (2018). Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Annals of the Rheumatic Diseases, 77(4), 563-570. Scopus60 WoS54 Europe PMC48 |
| 2018 | Guo, Y., Walsh, A., Canavan, M., Wechalekar, M., Cole, S., Yin, X., . . . Nagpal, S. (2018). Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression. PLoS ONE, 13(2), 17 pages. Scopus106 WoS96 Europe PMC82 |
| 2018 | Morrisroe, K., Sudararajan, V., Stevens, W., Sahhar, J., Zochling, J., Roddy, J., . . . Nikpour, M. (2018). Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life.. Rheumatology (Oxford, England), 57(1), 73-83. Scopus28 WoS26 Europe PMC21 |
| 2018 | Peytrignet, S., Denton, C. P., Lunt, M., Hesselstrand, R., Mouthon, L., Silman, A., . . . Herrick, A. L. (2018). Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.. Rheumatology (Oxford, England), 57(2), 370-381. Scopus58 WoS55 Europe PMC48 |
| 2017 | Morrisroe, K., Stevens, W., Sahhar, J., Ngian, G., Rabusa, C., Ferdowsi, N., . . . Nikpour, M. (2017). Quantifying the direct public health care cost of systemic sclerosis. Medicine, 96(48), e8503-1-e8503-11. Scopus21 WoS19 Europe PMC15 |
| 2017 | Hopkins, A., Vitry, A., O'Doherty, C., Proudman, S., & Wiese, M. (2017). Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease-modifying antirheumatic drugs have influenced the use of leflunomide. International Journal of Rheumatic Diseases, 20(11), 1795-1797. Scopus1 WoS1 Europe PMC1 |
| 2017 | Morrisroe, K., Stevens, W., Proudman, S., & Nikpour, M. (2017). A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adults. International Journal of Rheumatic Diseases, 20(11), 1728-1750. Scopus15 WoS15 Europe PMC12 |
| 2017 | Rasch, L. A., Boers, M., Hill, C. L., Voshaar, M., Hoogland, W., De Wit, M., . . . Van Tuyl, L. H. D. (2017). Validating rheumatoid arthritis remission using the patients' perspective: Results from a special interest group at OMERACT 2016. Journal of Rheumatology, 44(12), 1889-1893. Scopus15 WoS14 Europe PMC13 |
| 2017 | Walsh, A., Wechalekar, M., Guo, Y., Yin, X., Weedon, H., Proudman, S., . . . Nagpal, S. (2017). Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways. PLoS ONE, 12(9), e0183928-1-e0183928-16. Scopus45 WoS43 Europe PMC40 |
| 2017 | Wabe, N., Wojciechowski, J., Wechalekar, M. D., Cleland, L. G., McWilliams, L., Lee, A., . . . Wiese, M. D. (2017). Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapy. International Journal of Rheumatic Diseases, 20(10), 1447-1456. Scopus13 WoS13 Europe PMC9 |
| 2017 | Herrick, A., Pan, X., Peytrignet, S., Lunt, M., Hesselstrand, R., Mouthon, L., . . . Denton, C. (2017). Treatment outcome in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study (ESOS). Annals of the Rheumatic Diseases, 76(7), 1207-1218. Scopus120 WoS113 Europe PMC93 |
| 2017 | Wabe, N., Lee, A., Wechalekar, M. D., McWilliams, L., Proudman, S. M., & Wiese, M. (2017). Adherence to combination DMARD therapy and treatment outcomes in rheumatoid arthritis: a longitudinal study of new and existing DMARD users. Rheumatology international, 37(6), 897-904. Scopus23 WoS25 Europe PMC21 |
| 2017 | Wechalekar, M., Quinn, S., Lester, S., Metcalf, R., Shanahan, E., Walker, J., . . . Proudman, S. (2017). A treat-to-target strategy preserves work capacity in a rheumatoid arthritis inception cohort treated with combination conventional DMARD therapy. Journal of Clinical Rheumatology, 23(3), 131-137. Scopus7 WoS7 Europe PMC7 |
| 2017 | Day, J., Limaye, V., Proudman, S., Hayball, J., & Hissaria, P. (2017). The utility of monitoring peripheral blood lymphocyte subsets by flow cytometric analysis in patients with rheumatological diseases treated with rituximab. Autoimmunity Reviews, 16(5), 542-547. Scopus7 WoS6 Europe PMC6 |
| 2017 | Morrisroe, K., Stevens, W., Sahhar, J., Rabusa, C., Nikpour, M., Proudman, S., . . . Zochling, J. (2017). Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme. Arthritis Research and Therapy, 19(1), 42-1-42-10. Scopus79 WoS75 Europe PMC59 |
| 2017 | Nikpour, M., Proudman, S., Morrisroe, K., Sahhar, J. M., & Stevens, W. (2017). The Australian scleroderma interest group and database: 10 years of screening to save lives. Medical Journal of Australia, 206(5), 229-229.e1. Scopus1 WoS1 Europe PMC1 |
| 2017 | Boulos, D., Ngian, G., Rajadurai, A., Elford, K., Stevens, W., Proudman, S., . . . Sahhar, J. (2017). Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease. International Journal of Rheumatic Diseases, 20(4), 481-488. Scopus18 WoS14 Europe PMC11 |
| 2017 | Otero, C., Assassi, S., Hudson, M., Mayes, M., Estrada-Y-Martin, R., Pedroza, C., . . . Fritzler, M. (2017). Antifibrillarin antibodies are associated with native north American ethnicity and poorer survival in systemic sclerosis. Journal of Rheumatology, 44(6), 799-805. Scopus32 WoS28 Europe PMC22 |
| 2017 | Tay, T., Ferdowsi, N., Baron, M., Stevens, W., Hudson, M., Proudman, S., . . . Damage Index Working Group of the Scleroderma Clinical Trials Consortium. (2017). Measures of disease status in systemic sclerosis: a systematic review. Seminars in Arthritis and Rheumatism, 46(4), 473-487. Scopus19 WoS17 Europe PMC14 |
| 2017 | Hoa, S., Stern, E. P., Denton, C. P., Hudson, M., Baron, M., Frech, T., . . . Varga, J. (2017). Towards developing criteria for scleroderma renal crisis: A scoping review. Autoimmunity Reviews, 16(4), 407-415. Scopus37 Europe PMC25 |
| 2017 | Ramos-Remus, C., Ramirez-Gomez, A., Brambila-Barba, V., Barajas-Ochoa, A., Castillo-Ortiz, J. D., Adebajo, A. O., . . . Besada, E. (2017). Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey. Clinical Rheumatology, 36(3), 485-497. Scopus30 WoS28 Europe PMC23 |
| 2017 | Guo, Y., Walsh, A., Fearon, U., Smith, M., Wechalekar, M., Yin, X., . . . Nagpal, S. (2017). CD40L-dependent pathway is active at various stages of rheumatoid arthritis disease progression. Journal of Immunology, 198(11), 4490-4501. Scopus94 WoS89 Europe PMC87 |
| 2017 | Morrisroe, K., Stevens, W., Huq, M., Sahhar, J., Ngian, G., Zochling, J., . . . ustralian Scleroderma Interest Group (ASIG). (2017). Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosis. Clinical and Experimental Rheumatology, 35(4 Suppl. 106), S130-S137. Scopus11 WoS6 Europe PMC15 |
| 2017 | Morrisroe, K., Stevens, W., Huq, M., Prior, D., Sahhar, J., Ngian, G., . . . Walker, J. (2017). Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension. Arthritis Research and Therapy, 19(1), 122. Scopus64 WoS64 Europe PMC51 |
| 2017 | Proudman, S. M., Huq, M., Stevens, W., Wilson, M. E., Sahhar, J., Baron, M., . . . Hij, A. (2017). What have multicentre registries across the world taught us about the disease features of systemic sclerosis?. Journal of Scleroderma and Related Disorders, 2(3), 169-182. Scopus23 WoS23 |
| 2017 | Morrisroe, K., Stevens, W., Huq, M., Sahhar, J., Ngian, G. S., Zochling, J., . . . Walker, J. (2017). Validity of the PROMIS-29 in a large Australian cohort of patients with systemic sclerosis. Journal of Scleroderma and Related Disorders, 2(3), 188-195. Scopus13 WoS14 |
| 2017 | Tay, T., Huq, M., Ferdowsi, N., Stevens, W., Sahhar, J., Ngian, G. S., . . . Nikpour, M. (2017). Early accrual of organ damage in systemic sclerosis: Rationale for development of a disease damage index. Journal of Scleroderma and Related Disorders, 2(2), 127-134. Scopus4 WoS4 |
| 2017 | Day, J., Otto, S., Proudman, S., Hayball, J. D., & Limaye, V. (2017). Dysregulated innate immune function in the aetiopathogenesis of idiopathic inflammatory myopathies. Autoimmunity Reviews, 16(1), 87-95. Scopus16 WoS16 Europe PMC14 |
| 2017 | Hopkins, A., Moghaddami, M., Foster, D., Proudman, S., Upton, R., & Wiese, M. (2017). Intracellular CD3⁺ T-lymphocyte teriflunomide concentration is poorly correlated with and has greater variability than unbound plasma teriflunomide concentration. Drug Metabolism Disposition, 45(1), 8-16. Scopus9 WoS9 Europe PMC8 |
| 2017 | Hopkins, A. M., Wiese, M. D., O Doherty, C. E., & Proudman, S. M. (2017). Putting recommendations into practice: Australian rheumatologists’ opinions on leflunomide use in rheumatoid arthritis. Clinical Rheumatology, 36(4), 791-798. Scopus2 WoS2 Europe PMC2 |
| 2017 | Hao, Y., Hudson, M., Baron, M., Carreira, P., Stevens, W., Rabusa, C., . . . Nikpour, M. (2017). Early mortality in a multinational systemic sclerosis inception cohort. Arthritis and Rheumatology, 69(5), 1067-1077. Scopus181 WoS168 Europe PMC131 |
| 2017 | Foreman, C., Russo, P., Davies, N., Hissaria, P., Proudman, S., Hughes, T., & Limaye, V. (2017). Use of intravenous immunoglobulin therapy for myositis: an audit in South Australian patients. Internal Medicine Journal, 47(1), 112-115. Scopus11 WoS10 Europe PMC6 |
| 2017 | Wabe, N., Sorich, M., Wechalekar, M., Cleland, L., Mcwilliams, L., Lee, A., . . . Wiese, M. (2017). Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis. International Journal of Rheumatic Diseases, 20(5), 576-583. Scopus7 WoS7 Europe PMC7 |
| 2016 | Hopkins, A., Wiese, M., Proudman, S., O'Doherty, C., Upton, R., & Foster, D. (2016). Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis. British Journal of Clinical Pharmacology, 81(1), 113-123. Scopus20 WoS14 Europe PMC13 |
| 2016 | Hill, C., March, L., Aitken, D., Lester, S., Battersby, R., Hynes, K., . . . Jones, G. (2016). Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose. Annals of the Rheumatic Diseases, 75(1), 23-29. Scopus119 WoS101 Europe PMC88 |
| 2016 | Calderone, A., Stevens, W., Prior, D., Nandurkar, H., Gabbay, E., Proudman, S., . . . Nikpour, M. (2016). Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol. BMJ Open, 6(12), e011028-1-e011028-12. Scopus16 WoS15 Europe PMC12 |
| 2016 | Tieu, J., & Proudman, S. (2016). Systemic sclerosis a step-by-step guide to a difficult diagnosis. Medicine Today, 17(9), 47-54. |
| 2016 | Esposito, J., Brown, Z., Stevens, W., Sahhar, J., Rabusa, C., Zochling, J., . . . Nikpour, M. (2016). The association of low complement with disease activity in systemic sclerosis: a prospective cohort study. Arthritis Research and Therapy, 18(1), 246-1-246-12. Scopus16 WoS14 Europe PMC13 |
| 2016 | Morrisroe, K., Huq, M., Stevens, W., Rabusa, C., Proudman, S., & Nikpour, M. (2016). Determinants of unemployment amongst Australian systemic sclerosis patients: Results from a multicentre cohort study. Clinical and Experimental Rheumatology, 34(5), 79-84. Scopus26 WoS25 Europe PMC12 |
| 2016 | Morrisroe, K., Huq, M., Stevens, W., Rabusa, C., Proudman, S., Nikpour, M., & The Australian Scleroderma Interest Group (ASIG). (2016). Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study. BMC Pulmonary Medicine, 16(1), 134-1-134-8. Scopus47 WoS41 Europe PMC31 |
| 2016 | Valenzuela, A., Baron, M., Herrick, A., Proudman, S., Stevens, W., Rodriguez-Reyna, T., . . . Chung, L. (2016). Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study. Seminars in Arthritis and Rheumatism, 46(3), 344-349. Scopus73 WoS60 Europe PMC49 |
| 2016 | Wabe, N., Sorich, M., Wechalekar, M., Cleland, L., McWilliams, L., Lee, A., . . . Wiese, M. (2016). Effect of adherence to protocolized targeted intensifications of disease-modifying antirheumatic drugs on treatment outcomes in rheumatoid arthritis: results from an Australian early arthritis cohort. The Journal of Rheumatology, 43(9), 1643-1649. Scopus12 WoS11 Europe PMC8 |
| 2016 | Proudman, S., Nikpour, M., & Hudson, M. (2016). Improving care of autoimmune connective tissue diseases: Lessons from longitudinal cohorts. Best Practice and Research Clinical Rheumatology, 30(1), 1-2. |
| 2016 | Hoa, S., Hudson, M., Troyanov, Y., Proudman, S., Walker, J., Stevens, W., . . . Fritzler, M. J. (2016). Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: Clinical associations. Medicine (United States), 95(35), 12 pages. Scopus58 WoS50 Europe PMC44 |
| 2016 | Wojciechowski, J., Wiese, M., Proudman, S., Foster, D., & Upton, R. (2016). A model-based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activity. British Journal of Clinical Pharmacology, 81(6), 1046-1057. Europe PMC1 |
| 2016 | Hopkins, A., Proudman, S., Vitry, A., Sorich, M., Cleland, L., & Wiese, M. (2016). Ten years of publicly funded biological disease-modifying antirheumatic drugs in Australia. Medical Journal of Australia, 204(2), 64-68.e1. Scopus16 WoS14 Europe PMC9 |
| 2016 | Khanna, D., Berrocal, V., Giannini, E., Seibold, J., Merkel, P., Mayes, M., . . . Furst, D. (2016). The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis. Arthritis and Rheumatology, 68(2), 299-311. Scopus127 WoS128 Europe PMC101 |
| 2016 | Khanna, D., Berrocal, V. J., Giannini, E. H., Seibold, J. R., Merkel, P. A., Mayes, M. D., . . . Furst, D. E. (2016). The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis. Arthritis Care and Research, 68(2), 167-178. Scopus18 WoS15 Europe PMC12 |
| 2016 | Wechalekar, M., Lester, S., Hill, C., Lee, A., Rischmueller, M., Smith, M., . . . Proudman, S. (2016). Active foot synovitis in patients with rheumatoid arthritis: unstable remission status, radiographic progression, and worse functional outcomes in patients with foot synovitis in apparent remission. Arthritis Care and Research, 68(11), 1616-1623. Scopus36 WoS35 Europe PMC27 |
| 2016 | Wabe, N., Sorich, M., Wechalekar, M., Cleland, L., McWilliams, L., Lee, A., . . . Wiese, M. (2016). Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term?. International Journal of Clinical Practice, 70(4), 340-350. Scopus2 WoS2 Europe PMC1 |
| 2016 | Owen, C., Ngian, G., Elford, K., Moore, O., Stevens, W., Nikpour, M., . . . Sahhar, J. (2016). Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort study. Clinical and Experimental Rheumatology, 34(5 (Suppl.100)), 170-176. Scopus45 WoS37 Europe PMC21 |
| 2016 | Nenke, M., Lewis, J., Rankin, W., McWilliams, L., Metcalf, R., Proudman, S., & Torpy, D. (2016). Reduced corticosteroid-binding globulin cleavage in active rheumatoid arthritis. Clinical Endocrinology, 85(3), 369-377. Scopus12 WoS9 Europe PMC9 |
| 2016 | Hynes, K., Bright, R., Proudman, S., Haynes, D., Gronthos, S., & Bartold, M. (2016). Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models: a systematic review. Seminars in Arthritis and Rheumatism, 46(1), 1-19. Scopus22 WoS19 Europe PMC17 |
| 2016 | Nikpour, M., Prior, D., Proudman, S., & Stevens, W. (2016). Author reply. Internal Medicine Journal, 46(6), 751-752. |
| 2016 | Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Sahhar, J., G Walker, J., . . . Nikpour, M. (2016). The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study. Clinical and Experimental Rheumatology, 34(5 (Suppl.100)), 129-136. Scopus20 WoS10 Europe PMC12 |
| 2016 | Khanna, D., Denton, C., Merkel, P., Krieg, T., Le Brun, F., Marr, A., . . . Balbir-Gurman, A. (2016). Effect of macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: Dual-1 and Dual-2 randomized clinical trials. JAMA - Journal of the American Medical Association, 315(18), 1975-1988. Scopus109 Europe PMC80 |
| 2016 | Tieu, J., Lester, S., Whittle, S., Peh, C. A., Goldblatt, F., Proudman, S., . . . Hill, C. (2016). RITUXIMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS: A REVIEW OF USE IN SOUTH AUSTRALIA. INTERNAL MEDICINE JOURNAL, 46, 35. |
| 2016 | Leclair, V., Hudson, M., Proudman, S. M., Stevens, W. M., Fritzler, M. J., Wang, M., . . . Youssef, P. (2016). Subsets in systemic sclerosis: One size does not fit all. Journal of Scleroderma and Related Disorders, 1(3), 298-306. Scopus12 WoS13 |
| 2015 | Wechalekar, M. D., Lester, S., Rischmueller, M., Hill, C., & Proudman, S. (2015). Foot Synovitis in Patients with Rheumatoid Arthritis in Apparent Remission Is Associated with Unstable Remission Status, Radiographic Progression and Worse Long-Term Functional Outcomes. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages. |
| 2015 | Wabe, N., Sorich, M., Wechalekar, M., Cleland, L., McWilliams, L., Lee, A., . . . Wiese, M. D. (2015). Effects of Drug Induced Toxicity on Patient Reported Outcomes in Early Rheumatoid Arthritis Treated-to-Target Using Conventional Triple DMARD Therapy. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages. |
| 2015 | Johnson, S. R., Elarabi, M., Proudman, S., Frech, T. M., Sahhar, J., Stevens, W., . . . Hudson, M. (2015). Exposure to ACE Inhibitors Prior to Onset of Scleroderma Renal Crisis Is Not Associated with Increased Risk of Mortality in a Large Retrospective Cohort Study. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages. |
| 2015 | Valenzuela, A., Baron, M., Herrick, A. L., Proudman, S., Stevens, W., Sofia Rodriguez-Reyna, T., . . . Chung, L. (2015). Calcinosis Is Associated with Digital Ulcers and Osteoporosis in Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages. |
| 2015 | Hudson, M., Baron, M., Wang, M., Rabusa, C., Proudman, S., Nikpour, M., & Stevens, W. (2015). Health-Related Quality of Life in Early Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages. |
| 2015 | Ferdowsi, N., Huq, M., Burchell, J., Mancuso, S., Tay, T., Stevens, W., . . . Nikpour, M. (2015). Development of a Disease Damage Index in Systemic Sclerosis Using Consensus and Data Driven Methods. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages. |
| 2015 | Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Fritzler, M. J. (2015). Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects. Autoimmunity, 48(8), 542-551. Scopus32 WoS28 Europe PMC24 |
| 2015 | Moore, O. A., Proudman, S. M., Goh, N., Corte, T. J., Rouse, H., Hennessy, O., . . . Nikpour, M. (2015). Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Clinical and Experimental Rheumatology, 33(4 (Suppl. 91)), 111-116. Scopus74 WoS74 |
| 2015 | Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Salazar, G. (2015). Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: Evidence of an association with interstitial lung disease and worse survival. Clinical and Experimental Rheumatology, 33(4 (suppl.91)), 131-135. Scopus67 WoS62 Europe PMC48 |
| 2015 | Bartold, P., & Proudman, S. (2015). Is there evidence indicating a link between periodontitis and rheumatoid arthritis?. International Journal of Clinical Rheumatology, 10(4), 215-218. |
| 2015 | Quinlivan, A., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., . . . Nikpour, M. (2015). Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal, 45(11), 1134-1140. Scopus21 WoS21 Europe PMC17 |
| 2015 | Hopkins, A., Wiese, M., Proudman, S., O'Doherty, C., Foster, D., & Upton, R. (2015). Semiphysiologically based pharmacokinetic model of leflunomide disposition in rheumatoid arthritis patients. CPT: Pharmacometrics and Systems Pharmacology, 4(6), 362-371. Scopus16 WoS15 Europe PMC11 |
| 2015 | Patterson, K., Roberts-Thomson, P., Lester, S., Tan, J., Hakendorf, P., Rischmueller, M., . . . Walker, J. (2015). Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (Scleroderma) cohort using principal components analysis. Arthritis and Rheumatology, 67(12), 3234-3244. Scopus104 WoS97 Europe PMC71 |
| 2015 | Proudman, S., Cleland, L., Metcalf, R., Sullivan, T., Spargo, L., & James, M. (2015). Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritis. The British Journal of Nutrition, 114(06), 885-890. Scopus31 WoS30 Europe PMC25 |
| 2015 | Thakkar, V., Nikpour, M., Stevens, W. M., & Proudman, S. M. (2015). Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension. Internal Medicine Journal, 45(3), 248-254. Scopus9 WoS9 Europe PMC9 |
| 2015 | Bright, R., Proudman, S., Rosenstein, E., & Bartold, P. (2015). Is there a link between carbamylation and citrullination in periodontal disease and rheumatoid arthritis?. Medical Hypotheses, 84(6), 570-576. Scopus31 WoS27 Europe PMC22 |
| 2015 | Moghaddami, M., James, M., Proudman, S., & Cleland, L. (2015). Synovial fluid and plasma n3 long chain polyunsaturated fatty acids in patients with inflammatory arthritis. Prostaglandins Leukotrienes and Essential Fatty Acids, 97, 7-12. Scopus10 WoS8 Europe PMC6 |
| 2015 | Wabe, N., Sorich, M., Wechalekar, M., Cleland, L., McWilliams, L., Lee, A., . . . Wiese, M. (2015). Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years. Arthritis Research and Therapy, 17(1), 48-1-48-14. Scopus23 WoS23 Europe PMC19 |
| 2015 | Mohamed, H., Sorich, M., Kowalski, S., McKinnon, R., Proudman, S., Cleland, L., & Wiese, M. (2015). The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies - a systematic review. European Journal of Clinical Pharmacology, 71(4), 411-423. Scopus27 WoS25 Europe PMC19 |
| 2015 | Khanna, D., Mittoo, S., Aggarwal, R., Proudman, S., Dalbeth, N., Matteson, E., . . . Strand, V. (2015). Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - report from OMERACT CTD-ILD Working Group. The Journal of rheumatology, 42(11), 2168-2171. Scopus160 WoS154 Europe PMC130 |
| 2015 | Morrisroe, K. B., Nikpour, M., & Proudman, S. M. (2015). Musculoskeletal manifestations of systemic sclerosis. Rheumatic Disease Clinics of North America, 41(3), 507-518. Scopus59 WoS51 Europe PMC41 |
| 2015 | Wojciechowski, J., Wiese, M., Proudman, S., Foster, D., & Upton, R. (2015). A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine. British journal of clinical pharmacology, 79(5), 777-788. Scopus6 WoS5 Europe PMC6 |
| 2015 | Hao, Y., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., . . . Nikpour, M. (2015). A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research and Therapy, 17(1), 23. Scopus103 WoS102 Europe PMC85 |
| 2015 | Proudman, S., James, M., Spargo, L., Metcalf, R., Sullivan, T., Rischmueller, M., . . . Cleland, L. (2015). Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Annals of the Rheumatic Diseases, 74(1), 89-95. Scopus130 WoS114 Europe PMC97 |
| 2015 | McComish, J., Mundy, J., Sullivan, T., Proudman, S., & Hissaria, P. (2015). Changes in peripheral blood B cell subsets at diagnosis and after treatment with disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: correlation with clinical and laboratory parameters. International Journal of Rheumatic Diseases, 18(4), 421-432. Scopus20 WoS21 Europe PMC22 |
| 2014 | Wiese, M., Alotaibi, N., O'Doherty, C., Sorich, M., Suppiah, V., Cleland, L., & Proudman, S. (2014). Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis. Pharmacogenomics Journal, 14(4), 350-355. Scopus24 WoS21 Europe PMC21 |
| 2014 | Saketkoo, L., Mittoo, S., Huscher, D., Khanna, D., Dellaripa, P., Distler, O., . . . Seibold, J. (2014). Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials. Thorax, 69(5), 428-436. Scopus108 WoS107 Europe PMC92 |
| 2014 | Cleland, L. G., Proudman, S. M., & James, M. J. (2014). RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. Journal of the National Cancer Institute, 106(4), dju022-1. Scopus3 WoS2 Europe PMC2 |
| 2014 | Kaur, S., Bright, R., Proudman, S., & Bartold, P. (2014). Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 44(2), 113-122. Scopus116 WoS86 Europe PMC82 |
| 2014 | Hopkins, A., O'Doherty, C., Foster, D., Suppiah, V., Upton, R., Spargo, L., . . . Wiese, M. (2014). The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity. Journal of Clinical Pharmacy and Therapeutics, 39(5), 555-560. Scopus6 WoS5 Europe PMC4 |
| 2014 | Hopkins, A. M., O'Doherty, C. E., Foster, D. J. R., Upton, R. N., Proudman, S. M., & Wiese, M. D. (2014). Individualization of leflunomide dosing in rheumatoid arthritis patients. Personalized Medicine, 11(4), 449-461. Scopus7 WoS8 Europe PMC5 |
| 2014 | Black, R. J., Spargo, L., Schultz, C., Chatterton, B., Cleland, L., Lester, S., . . . Proudman, S. M. (2014). Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis. Arthritis Care & Research, 66(4), 515-522. Scopus14 WoS14 Europe PMC10 |
| 2014 | Vacca, A., Meune, C., Gordon, J., Chung, L., Proudman, S., Assassi, S., . . . Allanore, Y. (2014). Cardiac arrhythmias and conduction defects in systemic sclerosis. Rheumatology, 53(7), 1172-1177. Scopus94 WoS84 Europe PMC69 |
| 2014 | Morrisroe, K., Stevens, W., Nandurkar, H., Prior, D., Thakkar, V., Roddy, J., . . . Nikpour, M. (2014). The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis. Clinical and Experimental Rheumatology, 32(6 Suppl. 86), S133-S137. Scopus32 WoS23 Europe PMC19 |
| 2014 | Hudson, M., Baron, M., Tatibouet, S., Furst, D., Khanna, D., Hummers, L., . . . Westhovens, R. (2014). Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey. Seminars in Arthritis and Rheumatism, 43(5), 666-672. Scopus121 Europe PMC81 |
| 2014 | Lake, F., & Proudman, S. (2014). Rheumatoid arthritis and lung disease: from mechanisms to a practical approach. Seminars in Respiratory and Critical Care Medicine, 35(2), 222-238. Scopus65 WoS57 Europe PMC40 |
| 2014 | Osthoff, M., Ngian, G., Dean, M., Nikpour, M., Stevens, W., Proudman, S., . . . Sahhar, J. (2014). Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study. Arthritis Research and Therapy, 16(1), 480-1-480-11. Scopus21 WoS20 Europe PMC18 |
| 2014 | Zochling, J., Newell, F., Charlesworth, J., Leo, P., Stankovich, J., Cortes, A., . . . Brown, M. (2014). An immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3. Arthritis Research & Therapy, 16(5), 438-1-438-7. Scopus64 WoS54 Europe PMC44 |
| 2014 | Wiese, M. D., Hopkins, A., Spargo, L., McWilliams, L., O'Doherty, C., Cleland, L. G., & Proudman, S. (2014). Patient, Genetic and Disease Factors Influence the Response to the Disease Modifying Anti-Rheumatic Drug Leflunomide. ARTHRITIS & RHEUMATOLOGY, 66, S1102. WoS1 |
| 2013 | Thakkar, V., Stevens, W., Prior, D., Youssef, P., Liew, D., Gabbay, E., . . . Nikpour, M. (2013). The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Research & Therapy, 15(6), R193-1-R193-11. Scopus64 WoS61 Europe PMC51 |
| 2013 | Nikpour, M., Stevens, W., Proudman, S., Buchbinder, R., Prior, D., Zochling, J., . . . Nandurkar, H. (2013). Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?. Internal Medicine Journal, 43(5), 599-603. Scopus12 WoS11 Europe PMC9 |
| 2013 | Moore, O., Goh, N., Corte, T., Rouse, H., Hennessy, O., Thakkar, V., . . . Nikpour, M. (2013). Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology, 52(1), 155-160. Scopus169 WoS151 Europe PMC120 |
| 2012 | Ngian, G., Sahhar, J., Proudman, S., Stevens, W., Wicks, I., & Van Doornum, S. (2012). Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis. ARD online, 71(12), 1980-1983. Scopus100 WoS91 Europe PMC69 |
| 2012 | O'Doherty, C., Schnabl, M., Spargo, L., Cleland, L., James, M., Proudman, S., & Wiese, M. (2012). Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritis. Pharmagenomics, 13(12), 1427-1434. Scopus24 WoS24 Europe PMC23 |
| 2012 | Thakkar, V., Stevens, W., Prior, D., Moore, O., Byron, J., Liew, D., . . . Nikpour, M. (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research & Therapy, 14(3), 1-10. Scopus99 WoS97 Europe PMC78 |
| 2012 | Graf, S., Lester, S., Nossent, J., Hill, C., Proudman, S., Lee, A., & Rischmueller, M. (2012). Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis. Arthritis Research & Therapy, 14(1), 1-7. Scopus34 WoS35 Europe PMC32 |
| 2012 | Wechalekar, M., Lester, S., Proudman, S., Cleland, L., Whittle, S., Rischmueller, M., & Hill, C. (2012). Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Arthritis and Rheumatism, 64(5), 1316-1322. Scopus51 WoS49 Europe PMC40 |
| 2012 | Ngian, G., Stevens, W., Prior, D., Gabbay, E., Roddy, J., Tran, A., . . . Nikpour, M. (2012). Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study. Arthritis Research & Therapy, 14(R213), 1-9. Scopus80 WoS79 Europe PMC66 |
| 2012 | Marchant, C., Smith, M., Proudman, S., Haynes, D., & Bartold, P. (2012). Effect of Porphyromonas gingivalis on citrullination of proteins by macrophages in vitro. Journal of Periodontology, Online(9), 1-15. Scopus15 WoS16 Europe PMC11 |
| 2012 | Wiese, M., Schnabl, M., O'Doherty, C., Spargo, L., Sorich, M., Cleland, L., & Proudman, S. (2012). Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis. Arthritis Research & Therapy, 14(4), 1-9. Scopus41 WoS37 Europe PMC32 |
| 2012 | Dalton, B., McNeil, K., Keogh, A., Williams, T., Proudman, S., Gabbay, E., . . . Boland, J. (2012). Design and delivery of an e-learning curriculum for physicians involved in the management of pulmonary hypertension. International Journal of Clinical Practice, 66(11), 1117-1124. Scopus1 |
| 2012 | Chen, J. Y., Limaye, V. S., Jain, R., Lu, T. Y., Proudman, S. M., & Raymond, G. L. (2012). Pulsed intravenous cyclophosphamide for SLE retinal vasculitis. Retinal Cases and Brief Reports, 6(1), 111-115. Scopus1 Europe PMC1 |
| 2011 | Black, R., Limaye, V., Proudman, S., Spargo, L., & Cleland, L. (2011). THE UTILITY OF THE VITAL ACTIVITIES AND LIFESTYLE INDEX (VALI) IN THE ASSESSMENT OF FIBROMYALGIA PATIENTS. INTERNAL MEDICINE JOURNAL, 41, 28-29. |
| 2011 | Cohen, S., Proudman, S., Kivitz, A., Burch, F., Donohue, J., Burstein, D., . . . Zack, D. (2011). A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Research and Therapy, 13(4), R125-1-R125-12. Scopus218 WoS187 Europe PMC186 |
| 2011 | Nikpour, M., Hissaria, P., Byron, J., Sahhar, J., Micallef, M., Paspaliaris, W., . . . Stevens, W. (2011). Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort. Arthritis Research & Therapy, 13(6), 1-13. Scopus144 WoS127 Europe PMC110 |
| 2011 | Gregory, M., Lester, S., Cook-Johnson, R., Gibson, R., Proudman, S., Cleland, L., & James, M. (2011). Fatty acid desaturase 2 promoter mutation is not responsible for Δ6-desaturase deficiency. European Journal of Human Genetics, 19(11), 1202-1204. Scopus7 WoS5 Europe PMC5 |
| 2011 | Rakhila, H., Rozek, T., Hopkins, A., Proudman, S., Cleland, L., James, M., & Wiese, M. (2011). Quantitation of total and free teriflunomide (A77 1726) in human plasma by LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis, 55(2), 325-331. Scopus49 WoS44 Europe PMC26 |
| 2011 | Keogh, A., Strange, G., McNeil, K., Williams, T., Gabbay, E., Proudman, S., . . . Dalton, B. (2011). The Bosentan Patient Registry: long-term survival in pulmonary arterial hypertension. Internal Medicine Journal, 41(3), 227-234. Scopus27 WoS26 Europe PMC22 |
| 2011 | Ngian, G., Nikpour, M., Byron, J., Tran, A., Roddy, J., Minson, R., . . . Proudman, S. (2011). SURVIVAL IN AUSTRALIAN PATIENTS WITH CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION. INTERNAL MEDICINE JOURNAL, 41, 12. WoS2 |
| 2011 | Nikpour, M., Proudman, S., Byron, J., Zochling, J., Roddy, J., Sahhar, J., . . . Stevens, W. (2011). MORTALITY AND CAUSES OF DEATH IN AN AUSTRALIAN SYSTEMIC SCLEROSIS COHORT. INTERNAL MEDICINE JOURNAL, 41, 12. |
| 2011 | Bejarano, V., Conaghan, P. G., & Proudman, S. M. (2011). Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis (Annals of the Rheumatic Diseases (2009) 68, (761-763)). Annals of the Rheumatic Diseases, 70(8), 1519. |
| 2010 | Nikpour, M., Micallef, M., Byron, J., Hissaria, P., Paspaliaris, W., Sahhar, J., . . . Stevens, W. (2010). PREVALENCE AND CORRELATES OF ANTIBODIES TO RNA POLYMERASE Ill IN SYSTEMIC SCLEROSIS. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 28(2), S82. WoS1 |
| 2010 | Stevens, W., Byron, J., Nash, P., Zochling, J., Gabbay, E., Chan, M., . . . Proudman, S. (2010). PULMONARY ARTERIAL HYPERTENSION IN AN AUSTRALIAN SYSTEMIC SCLEROSIS COHORT. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 28(2), S76-S77. |
| 2010 | Proudman, S. (2010). Why screen patients with scleroderma for lung complications?. Medicine Today, 11(2), 63-68. |
| 2010 | Nikpour, M., Byron, J., Zochling, J., Chan, M., Nash, P., Sahhar, J., . . . Stevens, W. (2010). DESCRIBING ORGAN DAMAGE IN SYSTEMIC SCLEROSIS. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 28(2), S113-S114. |
| 2010 | Caughey, G., James, M., Proudman, S., & Cleland, L. (2010). Fish oil supplementation increases the cyclooxygenase inhibitory activity of paracetamol in rheumatoid arthritis patients. Complementary Therapies in Medicine, 18(3-4), 171-174. Scopus36 WoS32 Europe PMC20 |
| 2010 | Nikpour, M., Stevens, W., Herrick, A., & Proudman, S. (2010). Epidemiology of systemic sclerosis. Best Practice & Research Clinical Rheumatology, 24(6), 857-869. Scopus96 WoS82 Europe PMC74 |
| 2010 | Nikpour, M., Proudman, S. M., Goh, N. S., & Moutsopoulos, H. M. (2010). Interstitial lung disease in Sjogren's syndrome. Current Rheumatology Reviews, 6(2), 127-137. |
| 2010 | Mangat, P., Conron, M., Gabbay, E., & Proudman, S. M. (2010). Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians. Internal Medicine Journal, 40(7), 494-502. Scopus7 WoS6 Europe PMC6 |
| 2009 | Lester, S., Proudman, S., Lee, A., Hall, C., McWilliams, L., James, M., & Cleland, L. (2009). Treatment-induced stable, moderate reduction in blood cell counts correlate to disease control in early rheumatoid arthritis. Internal Medicine Journal, 39(5), 296-303. Scopus11 WoS10 Europe PMC9 |
| 2009 | Cleland, L., James, M., & Proudman, S. (2009). Dietary fats and inflammation: The medicinal use of fish oil. Nutrition & Dietetics, 66(1), 4-6. Scopus1 WoS1 |
| 2009 | Bejarano, V., Conaghan, P. G., Proudman, S. M., Buch, M. H., Brown, A. K., & Emery, P. (2009). Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis. Annals of the Rheumatic Diseases, 68(5), 761-763. Scopus7 Europe PMC3 |
| 2008 | Proudman, S., Cleland, L., & James, M. (2008). Dietary omega-3 fats for treatment of inflammatory joint disease: Efficacy and utility. Rheumatic Disease Clinics of North America, 34(2), 469-479. Scopus48 WoS46 Europe PMC31 |
| 2008 | Cai, F., Lester, S., Lu, T., Keen, H., Boundy, K., Proudman, S., . . . Rischmueller, M. (2008). Mild autonomic dysfunction in primary Sjogren's syndrome: a controlled study. Arthritis Research & Therapy, 10(2), R31-1-R31-10. Scopus40 WoS34 Europe PMC28 |
| 2008 | James, H., Gillis, D., Hissaria, P., Lester, S., Somogyi, A., Cleland, L., & Proudman, S. (2008). Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis. Journal of Rheumatology, 35(4), 562-571. Scopus57 WoS57 Europe PMC45 |
| 2008 | Philpott, H., Hissaria, P., Warren, L., Singhal, N., Brown, M., Proudman, S., . . . Gillis, D. (2008). Eosinophilic fasciitis as a paraneoplastic phenomenon associated with metastatic colorectal carcinoma. Australasian Journal of Dermatology, 49(1), 27-29. Scopus20 WoS16 Europe PMC10 |
| 2008 | Fock, K., Talley, N., Fass, R., Goh, K., Katelaris, P., Hunt, R., . . . Manatsathit, S. (2008). Asia-Pacific consensus on the management of gastroesophageal reflux disease: Update. Journal of Gastroenterology and Hepatology, 23(1), 8-22. Scopus159 WoS137 Europe PMC120 |
| 2007 | Proudman, S., Keen, H., Stamp, L., Lee, A., Goldblatt, F., Ayres, O., . . . Cleland, L. (2007). Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Seminars in Arthritis and Rheumatism, 37(2), 99-111. Scopus64 WoS65 Europe PMC54 |
| 2007 | Haugeberg, G., Green, M. J., Conaghan, P. G., Quinn, M., Wakefield, R., Proudman, S. M., . . . Emery, P. (2007). Hand bone densitometry: A more sensitive standard for the assessment of early bone damage in rheumatoid arthritis. Annals of the Rheumatic Diseases, 66(11), 1513-1517. Scopus39 WoS33 Europe PMC29 |
| 2007 | Cox, S. R., McWilliams, L., Massy Westropp, N. M., Meads, D. M., McKenna, S. P., & Proudman, S. (2007). Adaption of the RAQoL for use in Australia. Rheumatology International, 27(7), 661-666. Scopus12 WoS14 Europe PMC9 |
| 2007 | Marzo-Ortega, H., Green, M. J., Keenan, A. M., Wakefield, R. J., Proudman, S., & Emery, P. (2007). A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis. Arthritis Care and Research, 57(1), 154-160. Scopus25 WoS24 Europe PMC24 |
| 2007 | Proudman, S., Cleland, L., & James, M. (2007). Omega-3 fatty acids for early rheumatoid arthritis. Medicine Today, 8(12), 57-59. |
| 2007 | Proudman, S. M., Stevens, W. M., Sahhar, J., & Celermajer, D. (2007). Pulmonary arterial hypertension in systemic sclerosis: The need for early detection and treatment. Internal Medicine Journal, 37(7), 485-494. Scopus105 WoS100 Europe PMC86 |
| 2006 | Cleland, L. G., James, M. J., & Proudman, S. M. (2006). Erratum: Fish oil: What the prescriber needs to know (Arthritis Research and Therapy). Arthritis Research and Therapy, 8(4), 1 page. Scopus1 WoS1 |
| 2006 | Cleland, L., Caughey, G., James, M., & Proudman, S. (2006). Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. Journal of Rheumatology, 33(10), 1973-1979. Scopus103 WoS88 Europe PMC50 |
| 2006 | Roberts, L., Cleland, L., Thomas, R., & Proudman, S. (2006). Early combination disease modifying antirheumatic drug treatment for rheumatoid arthritis. Medical Journal of Australia, 184(3), 122-125. Scopus17 WoS11 Europe PMC7 |
| 2006 | Cleland, L., James, M., & Proudman, S. (2006). Fish oil: what the prescriber needs to know. Arthritis Research & Therapy, 8(1), WWW1-WWW9. Scopus113 WoS90 Europe PMC59 |
| 2006 | Haugeberg, G., Green, M. J., Quinn, M. A., Marzo-Ortega, H., Proudman, S., Karin, Z., . . . Emery, P. (2006). Hand bone loss in early undifferentiated arthritis: Evaluating bone mineral density loss before the development of rheumatoid arthritis. Annals of the Rheumatic Diseases, 65(6), 736-740. Scopus72 Europe PMC59 |
| 2005 | Cleland, L., James, M., Keen, H., Danda, D., Caughey, G., & Proudman, S. (2005). Fish oil - an example of an anti-inflammatory food. Asia Pacific Journal of Clinical Nutrition, 14(SUPPL.), 66-71. Scopus10 |
| 2005 | Cox, S., Walker, J., Coleman, M., Rischmueller, M., Proudman, S., Smith, M., . . . Roberts-Thomson, P. (2005). Isolated pulmonary hypertension in scleroderma. Internal Medicine Journal, 35(1), 28-33. Scopus65 WoS60 Europe PMC45 |
| 2005 | Broadfoot, A., Gillis, D., & Proudman, S. (2005). Lack of association of antineutrophil cytoplasmic antibodies with joint failure as indicated by joint surgery in rheumatoid arthritis. Aplar Journal of Rheumatology, 8(1), 54-59. |
| 2004 | Wakefield, R., Green, M., Marzo-Ortega, H., Conaghan, P., Gibbon, W., McGonagle, D., . . . Emery, P. (2004). Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Annals of the Rheumatic Diseases, 63(4), 382-385. Scopus348 WoS318 Europe PMC227 |
| 2003 | Cleland, L., James, M., & Proudman, S. (2003). The role of fish oils in the treatment of rheumatoid arthritis. Drugs, 63(9), 845-853. Scopus156 WoS122 Europe PMC81 |
| 2003 | Cleland, L., Proudman, S., Hall, C., Stamp, L., McWilliams, L., Wylie, N., . . . James, M. (2003). A Biomarker of n-3 compliance in patients taking fish oil for rheumatoid arthritis. Lipids, 38(4), 419-424. Scopus20 WoS21 Europe PMC17 |
| 2003 | James, M., Proudman, S., & Cleland, L. (2003). Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis. Prostaglandins Leukotrienes and Essential Fatty Acids, 68(6), 399-405. Scopus50 WoS43 Europe PMC30 |
| 2003 | Quinn, M. A., Green, M. J., Marzo-Ortega, H., Proudman, S., Karim, Z., Wakefield, R. J., . . . Emery, P. (2003). Prognostic Factors in a Large Cohort of Patients With Early Undifferentiated Inflammatory Arthritis After Application of a Structured Management Protocol. Arthritis and Rheumatism, 48(11), 3039-3045. Scopus107 Europe PMC60 |
| 2003 | Conaghan, P. G., O'Connor, P., McGonagle, D., Astin, P., Wakefield, R. J., Gibbon, W. W., . . . Emery, P. (2003). Elucidation of the relationship between synovitis and bone damage: A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis and Rheumatism, 48(1), 64-71. Scopus329 Europe PMC225 |
| 2001 | Green, M., Marzo-Ortega, H., Wakefield, R., Astin, P., Proudman, S., Conaghan, P., . . . Emery, P. (2001). Predictors of outcome in patients with oligoarthritis - Results of a protocol of intraarticular corticosteroids to all clinically active joints. Arthritis and Rheumatism, 44(5), 1177-1183. Scopus44 WoS38 Europe PMC26 |
| 2001 | Cleland, L., Fusco, M., Proudman, S., Wing, S., Spargo, L., & Mayrhofer, G. (2001). Recruitment of mononuclear leucocytes to osteoarthritic human synovial xenografts in the ears of SCID mice. Immunology and Cell Biology, 79(4), 309-319. |
| 2000 | Cleland, L., Proudman, S., James, M., & Penglis, P. (2000). The changing treatment of arthritis. Australian Prescriber, 23(2), 26-27. Scopus1 |
| 2000 | Proudman, S. M., Conaghan, P. G., Richardson, C., Griffiths, B., Green, M. J., Mcgonagle, D., . . . Emery, P. (2000). Treatment of poor-prognosis early rheumatoid arthritis: A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis and Rheumatism, 43(8), 1809-1819. Scopus141 Europe PMC73 |
| 1999 | Proudman, S., Cleland, L., & Mayrhofer, G. (1999). Effects of TNF-a, IL-1b and activated peripheral blood mononuclear cells on the expression of adhesion molecules and recruitment of leukocytes in rheumatoid synovial xenografts in SCID mice.. Journal of Rheumatology, 26(9), 1877-1889. Scopus27 WoS24 Europe PMC20 |
| 1999 | Proudman, S., Cleland, L., & Mayrhofer, G. (1999). Effects of Tumor Necrosis Factor-a, Interleukin 1B, and Activated Peripheral Blood Mononuclear Cells on the Expression of Adhesion Molecules and Recruitment of Leukocytes in Rheumatoid Synovial Xenografts in SCID Mice. Journal of Rheumatology, 26(9, September 1999), 1877-1889. |
| 1999 | Proudman, S., Cleland, L., Fusco, M., & Mayrhofer, G. (1999). Accessible xenografts of human synovium in the subcutaneous tissues of the ears of SCID mice. Immunology and Cell Biology, 77(2, April 1999), 109-120. Scopus6 WoS7 Europe PMC4 |
| 1999 | Green, M., Marzo-Ortega, H., McGonagle, D., Wakefield, R., Proudman, S., Conaghan, P., . . . Emery, P. (1999). Persistence of mild, early inflammatory arthritis: The importance of disease duration, rheumatoid factor, and the shared epitope. Arthritis and Rheumatism, 42(10), 2184-2188. Scopus175 WoS139 Europe PMC95 |
| 1994 | Hawkes, J. S., Cleland, L. G., Proudman, S. M., & James, M. J. (1994). The effect of methotrexate on ex vivo lipoxygenase metabolism in neutrophils from patients with rheumatoid arthritis. Journal of Rheumatology, 21(1), 55-58. Scopus21 WoS21 Europe PMC17 |
| 1994 | Cleland, L. G., James, M. J., Proudman, S. M., Neumann, M. A., & Gibson, R. A. (1994). Inhibition of human neutrophil leukotriene B4 synthesis in essential fatty acid deficiency: Role of leukotriene a hydrolase. Lipids, 29(3), 151-155. Scopus21 WoS20 Europe PMC13 |
| 1994 | James, M. J., Cleland, L. G., Gaffney, R. D., Proudman, S. M., & Chatterton, B. E. (1994). Effect of exercise on 99mTc-DTPA clearance from knees with effusions. Journal of Rheumatology, 21(3), 501-504. Scopus29 WoS23 Europe PMC22 |
| 1992 | Proudman, S. M., & Cleland, L. G. (1992). Auranofin‐induced vasomotor reaction. Arthritis Rheumatism, 35(12), 1452-1454. Scopus4 WoS5 Europe PMC2 |
| 1992 | CLELAND, L. G., JAMES, M. J., PROUDMAN, S. M., NEUMANN, M., & GIBSON, R. A. (1992). INHIBITION OF HUMAN NEUTROPHIL LEUKOTRIENE-B4 PRODUCTION BY N-9 EICOSTRIENOIC ACID. ARTHRITIS AND RHEUMATISM, 35(9), S36. |
| Year | Citation |
|---|---|
| 2024 | Kumar, K., Maundrell, A., & Proudman, S. M. (2024). Epidemiology of Raynaud’s Phenomenon. In Raynauds Phenomenon from Pathogenesis to Management Second Edition (pp. 25-40). Springer Nature Switzerland. DOI Scopus2 |
| 2014 | Maundrell, A., & Proudman, S. M. (2014). Epidemiology of Raynaud’s Phenomenon. In Raynauds Phenomenon A Guide to Pathogenesis and Treatment (pp. 21-35). DOI Scopus26 |
| 2003 | Cleland, L., James, M., & Proudman, S. (2003). Omega-6/Omega-3 fatty acids and arthritis. In A. Simopoulos, & L. Cleland (Eds.), Omega-6/Omega-3 essential fatty acid ratio: the scientific evidence (Vol. 92, pp. 152-168). PO Box, CH-4009 Basel, Switzerland: S Karger AG. DOI Scopus20 Europe PMC6 |
| Year | Citation |
|---|---|
| 2025 | Parker, M., Nikpour, M., Hansen, D., Hanson, A., Sahhar, J. A. M., Brown, M., . . . Kenna, T. (2025). HIGH SERUM LEVELS OF VASCULAR CELL ADHESION MOLECULE 1 ASSOCIATE WITH A VASCULOPATHIC PHENOTYPE IN SYSTEMIC SCLEROSIS WITH HIGHER MORTALITY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 84 (pp. 2 pages). SPAIN, Barcelona: ELSEVIER. DOI |
| 2025 | Shen, H. C., Hudson, M., Proudman, S. M., Walker, J. G., Stevens, W., Nikpour, M., . . . Hoa, S. (2025). ANTI-NOR-90 ANTIBODIES IN AN INTERNATIONAL COHORT OF 2140 SYSTEMIC SCLEROSIS SUBJECTS: CLINICAL ASSOCIATIONS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 84 (pp. 1069-1070). ELSEVIER. DOI |
| 2025 | Ross, L., Hansen, D., Proudman, S. M., Walker, J., Stevens, W., Ferdowsi, N., . . . Volkmann, E. R. (2025). DEFINING CLINICAL PHENOTYPES OF GASTROINTESTINAL DISEASE IN SYSTEMIC SCLEROSIS BY FACTOR ANALYSIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 84 (pp. 1067-1068). ELSEVIER. DOI |
| 2025 | Goodwin, S., Wigg, A., Schwetlik, S., Lester, S., Stanhope, J., Dyer, K., . . . Hill, C. (2025). Bridging the gap to community care: an allied health-led, self-management group for rheumatology outpatients. In International Journal of Rheumatic Diseases Vol. 28 (pp. 9). Adelaide: Wiley. |
| 2025 | Chim, I., Stanhope, J., Dyer, K., Simon, S., Ruediger, C., Lyne, S., . . . Hill, C. (2025). Associations and outcomes of ocular giant cell arteritis (GCA): a sub-group analysis of the South Australian GCA Registry. In International Journal of Rheumatic Diseases Vol. 28 (pp. 51). Adelaide: Wiley. |
| 2025 | Lai, V., Hansen, D., Tabesh, M., Fairley, J., Ross, L., Ferdowsi, N., . . . Saracino, A. (2025). Mucocutaneous telangiectasia in systemic sclerosis is a marker of increased disease morbidity and mortality: Data from the Australian Scleroderma Cohort Study. In AUSTRALASIAN JOURNAL OF DERMATOLOGY Vol. 66 (pp. 1 page). WILEY. |
| 2024 | Rodriguez-Martin, I., Kerick, M., Rosa-Baez, C., Borrego-Yaniz, G., Ortiz-Fernandez, L., Guillen-Del-Castillo, A., . . . Acosta-Herrera, M. (2024). INVESTIGATING THE GENETIC BACKGROUND OF THE SEX DIMORPHISM IN SYSTEMIC SCLEROSIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83 (pp. 2 pages). ELSEVIER. |
| 2024 | Rodriguez-Martin, I., Kerick, M., Rosa-Baez, C., Borrego-Yaniz, G., Ortiz-Fernandez, L., Guillen-Del-Castillo, A., . . . Acosta-Herrera, M. (2024). INVESTIGATING THE GENETIC BACKGROUND OF THE SEX DIMORPHISM IN SYSTEMIC SCLEROSIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83 (pp. 2 pages). AUSTRIA, Vienna: ELSEVIER. DOI |
| 2024 | Lowe, K., Kasparian, J., Small, A., Weedon, H., Masle-Farquhar, E., Singh, M., . . . Wechalekar, M. (2024). CHARACTERISATION OF SIGNALLING LYMPHOCYTIC ACTIVATION MOLECULES (SLAM) IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83 (pp. 2 pages). AUSTRIA, Vienna: ELSEVIER. DOI WoS1 |
| 2024 | Lowe, K., Small, A., Wong, S. W., Weedon, H., Altmann, C., Proudman, S. M., . . . Wechalekar, M. (2024). NEXT GENERATION SEQUENCING IDENTIFIES DIFFERENCES IN THE TRANSCRIPTOMIC PROFILE OF PRETREATMENT EARLY RHEUMATOID ARTHRITIS SYNOVIAL TISSUE FROM RESPONDERS AND NON RESPONDERS TARGETED TO ADALIMUMAB. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83 (pp. 2 pages). AUSTRIA, Vienna: ELSEVIER. |
| 2024 | Egberts, B., Ananthakrishna, R., Shah, R. J., Regalado, J. J., Sutton, A., Mcwilliams, L., . . . Selvanyagam, J. B. (2024). Assessment of sub clinical right ventricular ischemia using oxygen sensitive cardiac magnetic resonance imaging in patients with systemic sclerosis: mechanistic insights from advanced cardiac imaging. In EUROPEAN HEART JOURNAL Vol. 45 (pp. 2 pages). OXFORD UNIV PRESS. DOI |
| 2024 | Andreasson, K., Joshi, S., Labus, J., Young, A., Low, A., Smith, V., . . . Volkmann, E. (2024). FECAL MICROBIOTA SIGNATURES OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: AN EXPLORATION OF THE GUT-LUNG AXIS IN AN INTERNATIONAL MULTICENTER STUDY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83 (pp. 2 pages). AUSTRIA, Vienna: ELSEVIER. DOI |
| 2024 | Chin, A., Branford, S., Small, A., Lowe, K., Smith, M., Kutyna, M., . . . Wechalekar, M. (2024). Clonal Haematopoiesis of Indeterminate Potential (CHIP) Is Associated with Disease Activity in Rheumatoid Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 76 (pp. 73-75). WILEY. |
| 2024 | Young, A., Andreasson, K., Joshi, S., Labus, J., Ling, A. L. H., Smith, V., . . . Volkmann, E. (2024). Association Between Gastrointestinal Bacterial Species and Radiological Features of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD): A Multicenter Study from the SSc Microbiome Consortium Project. In ARTHRITIS & RHEUMATOLOGY Vol. 76 (pp. 5443-5445). WILEY. |
| 2024 | Strathmore, A., Hansen, D., Morrisroe, K., Quinlivan, A., Proudman, S., Walker, J., . . . Basnayake, C. (2024). Decoding gastrointestinal symptoms in systemic sclerosis: a cluster analysis of a large national prospective systemic sclerosis cohort. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 39 (pp. 300-301). WILEY. |
| 2024 | Madigan, S., Proudman, S., Schembri, D., Davies, H., & Adams, R. (2024). Changes in physiological parameters measured by cardiopulmonary exercise testing in patients with systemic sclerosis. In RESPIROLOGY Vol. 29 (pp. 9). WILEY. |
| 2024 | Madigan, S., Proudman, S., Schembri, D., Davies, H., & Adams, R. (2024). Physiological changes measured by cardiopulmonary exercise testing in Systemic Sclerosis. In RESPIROLOGY Vol. 29 (pp. 171). WILEY. |
| 2024 | Quinlivan, A., Hansen, D., Stevens, W., Ross, L., Ferdowsi, N., Proudman, S. M., . . . Nikpour, M. (2024). Prevalence and Outcomes of Gastrointestinal Manifestations in an Australian Scleroderma Cohort. In Arthritis Care and Research Vol. 76 (pp. 1686-1695). United States: WILEY. DOI Scopus3 WoS5 Europe PMC3 |
| 2023 | Bhushan, V., Limaye, V., Hansen, D., McWilliams, L., Maundrell, A., Morrisroe, K., . . . Proudman, S. (2023). DEVELOPMENT OF A PRELIMINARY SCREENING ALGORITHM TO DETECT SYSTEMIC SCLEROSIS-RELATED MYOPATHY. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 41 (pp. 532). CLINICAL & EXPER RHEUMATOLOGY. WoS1 |
| 2023 | Albanese, D., Sunny, L., Al Naji, H., Limaye, V., Bursill, D., Black, R., . . . Proudman, S. (2023). ADHERENCE TO RECOMMENDED SCREENING TESTS PRIOR TO COMMENCING METHOTREXATE IN RHEUMATOLOGY PATIENTS: A DEPARTMENTAL AUDIT. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 9). WILEY. |
| 2023 | Sunny, L., Albanese, D., Al Naji, H., Limaye, V., Bursill, D., Black, R., . . . Proudman, S. (2023). ADHERENCE TO THE RECOMMENDED SCREENING TESTS PRIOR TO COMMENCING BIOLOGIC/TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOLOGY PATIENTS: A DEPARTMENTAL AUDIT. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 51). WILEY. |
| 2023 | Gregory, K., Hansen, D., Penglase, R., Stevens, W., Apostolopoulos, D., Ngian, G. -S., . . . Sahhar, J. (2023). OUTCOMES OF USUAL CARE IN AUSTRALIAN SYSTEMIC SCLEROSIS PATIENTS WHO FULFIL CRITERIA FOR AUTOLOGOUS STEM CELL TRANSPLANTATION. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 32). WILEY. |
| 2023 | Fairley, J., Hansen, D., Baron, M., Proudman, S., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2023). EXPLORING THE BURDEN AND TRAJECTORY OF FATIGUE IN SYSTEMIC SCLEROSIS: CLINICAL CORRELATES AND IMPLICATIONS. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 44-45). WILEY. |
| 2023 | Russell, O., McWilliams, L., Hill, C., & Proudman, S. (2023). THE PATIENT EXPERIENCE OF TELEHEALTH IN RHEUMATOLOGY IN TWO METROPOLITAN SOUTH AUSTRALIAN HOSPITALS. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 41). WILEY. |
| 2023 | Small, A., Lowe, K., Smith, M., Hao, L. -Y., Nagpal, S., Proudman, S., & Wechalekar, M. (2023). THE TREATMENT-NAIVE RHEUMATOID ARTHRITIS METABOLOME. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 45). WILEY. |
| 2023 | Parker, M., Jee, A., Nikpour, M., Hansen, D., Stevens, W., Kenna, T., . . . Corte, T. (2023). THE PERFORMANCE OF SERUM BIOMARKERS IN PREDICTING MORTALITY AND DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 7). WILEY. |
| 2023 | Massolino, R., Griggs, K., Spurr, O., McWilliams, L., Xing, J., Hill, C., . . . Wiese, M. (2023). DEFINING THE TREATMENT GAP FOR PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TREAT-TO-TARGET THERAPY WHO DO NOT ACHIEVE REMISSION OR MEET THE PHARMACEUTICAL BENEFITS SCHEME CRITERIA FOR BIOLOGIC/TARGETED SYNTHETIC DMARDS. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 55). WILEY. |
| 2023 | Ming, J., Reeve, E., Chai, W. C., Ailabouni, N., Proudman, S., & Wiese, M. (2023). ATTITUDES OF HEALTHCARE PROFESSIONAL TOWARDS THE USE OF PARENTERAL METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS: A QUALITATIVE STUDY. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 30). WILEY. |
| 2023 | Schwetlik, S., Wigg, A., Tieu, J., Lyne, S., Whittle, S., Proudman, S., & Hill, C. (2023). THE VALUE OF AN ADVANCED PRACTICE PHYSIOTHERAPIST-LED NEW PATIENT RHEUMATOLOGY SERVICE: A CLINICAL AUDIT OF THE MUSCULOSKELETAL ASSESSMENT CLINIC AT THE QUEEN ELIZABETH HOSPITAL. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 17-18). WILEY. |
| 2023 | Fairley, J., Hansen, D., Day, J., Proudman, S., Sahhar, J., Ngian, G. -S., . . . Ross, L. (2023). SKELETAL MYOPATHY IN SYSTEMIC SCLEROSIS: CLINICAL CORRELATES, PROGNOSIS AND FUNCTIONAL IMPLICATIONS. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 6). WILEY. |
| 2023 | Wigg, A., Milanese, S., Ayres, A., Black, R., Limaye, V., & Proudman, S. (2023). DEVELOPMENT AND EVALUATION OF AN ADVANCED PRACTICE PHYSIOTHERAPIST-LED NEW PATIENT ASSESSMENT SERVICE IN AN AUSTRALIAN RHEUMATOLOGY OUTPATIENT SETTING. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 14). WILEY. |
| 2023 | Lee, A., Griggs, K., Hunter, P., McWilliams, L., Bursill, D., & Proudman, S. (2023). TOWARDS A SOUND DIAGNOSIS: USE OF RHEUMATOLOGICAL ULTRASOUND IN THE MANAGEMENT OF GOUT IN A DEDICATED CRYSTAL ARTHRITIS CLINIC WITH A TREAT TO TARGET APPROACH. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 54-55). WILEY. |
| 2023 | New-Tolley, J., Dyer, K., Lester, S., Burnet, S., Ting, K., Basnayake, S., . . . Hill, C. (2023). RHEUMATOID ARTHRITIS AND EXERCISE IN AUSTRALIA. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 41). WILEY. WoS1 |
| 2023 | Brown, Z., Hansen, D., McWilliams, L., Moghaddami, M., Stevens, W., Walker, J., . . . Proudman, S. (2023). PREDICTIVE ACCURACY OF THE ASIG AND DETECT SCREENING ALGORITHMS TO IDENTIFY PULMONARY ARTERIAL HYPERTENSION IN A PROSPECTIVE COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS UNDERGOING ANNUAL SCREENING. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 39). WILEY. |
| 2023 | Sukkar, M., Keen, H., March, L., Proudman, S., Bradbury, L., Hardy, L., . . . Hill, C. (2023). DEVELOPING QUALITY STANDARDS FOR THE DIAGNOSIS AND MANAGEMENT OF RHEUMATOID ARTHRITIS IN AUSTRALIA. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 52). WILEY. |
| 2023 | Lowe, K., Le, B., Small, A., Weedon, H., Proudman, S., Smith, M., . . . Wechalekar, M. (2023). BIOMARKERS OF BONE ACTIVITY IN RHEUMATOID ARTHRITIS SYNOVIAL TISSUE AND THEIR RELATIONSHIP WITH CLINICAL OUTCOME. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 10). WILEY. |
| 2023 | Ninan, J., Ruediger, C., Dyer, K. A., Dodd, T., Black, R. J., Lyne, S., . . . Hill, C. L. (2023). Incidence of biopsy-proven giant cell arteritis (GCA) in South Australia 2014–2020. In Frontiers in Medicine Vol. 10 (pp. 5 pages). Switzerland: FRONTIERS MEDIA SA. DOI Scopus2 WoS2 Europe PMC1 |
| 2023 | Robinson, L., Hamden, M., Griggs, K., Hill, C., Limaye, V., & Proudman, S. (2023). USE OF TOCILIZUMAB FOR GIANT CELL ARTERITIS IN PATIENTS WHO DO NOT MEET CRITERIA FOR PBS-SUBSIDIZED THERAPY. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 28). WILEY. |
| 2023 | Fairley, J., Hansen, D., Proudman, S., Sahhar, J. A., Ngian, G. S., Walker, J., . . . Ross, L. (2023). Left ventricular systolic dysfunction is rare but prognostically important in systemic sclerosis. In Abstracts of the European Congress of Rheumatology (EULAR 2023), as published in Annals of the Rheumatic Diseases Vol. 82 (pp. 1666-1667). Milan, Italy: BMJ Publishing Group. DOI |
| 2023 | Denton, C. P., Kowal-Bielecka, O., Proudman, S., Olesinska, M., Worm, M., Del Papa, N., . . . Gasior, M. (2023). SAFETY AND PHARMACOKINETICS OF IGPRO20 (SUBCUTANEOUS IMMUNOGLOBULIN) AND IGPRO10 (INTRAVENOUS IMMUNOGLOBULIN) IN ADULTS WITH SYSTEMIC SCLEROSIS (SSC) - RESULTS FROM A PHASE 2 TRIAL. In ANNALS OF THE RHEUMATIC DISEASES Vol. 82 (pp. 985). ITALY, Milan: BMJ PUBLISHING GROUP. DOI WoS1 |
| 2023 | Ross, L., Hansen, D., Proudman, S., Khanna, D., Herrick, A., Stevens, W., . . . Nikpour, M. (2023). DEVELOPMENT AND PRELIMINARY VALIDATION OF THE NOVEL SCLERODERMA CLINICAL TRIALS CONSORTIUM ACTIVITY INDEX. In ANNALS OF THE RHEUMATIC DISEASES Vol. 82 (pp. 155-156). ITALY, Milan: BMJ PUBLISHING GROUP. DOI WoS1 |
| 2023 | Ninan, J., Lyne, S., McNeil, J., Tieu, J., Limaye, V., Proudman, S., . . . Hill, C. (2023). Enhanced Diagnostic Confidence with High Frequency Temporal Artery Ultrasound in Diagnosis of Cranial Giant Cell Arteritis (GCA). In ARTHRITIS & RHEUMATOLOGY Vol. 75 (pp. 2066-2068). WILEY. |
| 2023 | Kumar, K., Matardiah, N. H. A. M., Griggs, K., Kunnel, A., Walker, J., & Proudman, S. (2023). Use of Heated Gloves for Raynaud's Phenomenon in Systemic Sclerosis. In ARTHRITIS & RHEUMATOLOGY Vol. 75 (pp. 1245-1247). WILEY. |
| 2023 | Proudman, S., Hughes, M., Maltez, N., Brown, E., Hickey, V., Grosskleg, S., . . . Merkel, P. (2023). Identifying Core Domains for Clinical Trials in Systemic Sclerosis-Associated Raynaud's Phenomenon and Digital Ulcers Using the Delphi Consensus Method. In ARTHRITIS & RHEUMATOLOGY Vol. 75 (pp. 2998-2999). WILEY. |
| 2023 | Ng, S. -A., Saffari, S. E., Stevens, W., Raja, J., Wangkaew, S., Ho, G., . . . Low, A. H. L. (2023). Clinical Characteristics of Systemic Sclerosis, Systemic Sclerosis Overlap Syndromes and Systemic Sclerosis-mixed Connective Tissue Disease in an Asia-Pacific Cohort- an APLAR Scleroderma Special Interest Group Study. In ARTHRITIS & RHEUMATOLOGY Vol. 75 (pp. 1281-1283). WILEY. |
| 2023 | Brown, Z., Hansen, D., Stevens, W., Ferdowsi, N., Ross, L., Quinlivan, A., . . . Nikpour, M. (2023). Application of the 2022 European Society of Cardiology (ESC) Risk Assessment Model in Australian and Singaporean Systemic Sclerosis Patients with Newly Diagnosed Pulmonary Arterial Hypertension (PAH). In ARTHRITIS & RHEUMATOLOGY Vol. 75 (pp. 1273-1275). WILEY. |
| 2023 | Barallon, R., Ngian, G. -S., Apostolopoulos, D., Hansen, D., Morrisroe, K., Stevens, W., . . . Sahhar, J. (2023). Prevalence and Associations of Anaemia in Systemic Sclerosis Patients in a National Observational Cohort; Results from the Australian Scleroderma Cohort Study. In ARTHRITIS & RHEUMATOLOGY Vol. 75 (pp. 1263-1265). WILEY. |
| 2023 | Hong, L. E., Kok, C. H., Kutyna, M., Li, J. J., Chhetri, R., Ross, D. M., . . . Hiwase, D. (2023). High Prevalence of IDH Mutation in Myeloid Neoplasm with Concomitant Autoimmune Rheumatic Disorders. In BLOOD Vol. 142 (pp. 4 pages). CA, San Diego: ELSEVIER. DOI |
| 2022 | Khoo, T., Jones, B., Chin, A., Terrett, A., Voshaar, M., Hoogland, W., . . . Proudman, S. (2022). Should Independence Play a Role in Assessing Remission in Rheumatoid Arthritis?. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 379-381). PA, Philadelphia: WILEY. |
| 2022 | Quinlivan, A., Neuen, D., Hansen, D., Stevens, W., Ross, L., Ferdowsi, N., . . . Nikpour, M. (2022). Gastroesophageal Reflux Disease in an Australian Scleroderma Cohort - Associations and Effect of Treatment. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 4284-4285). PA, Philadelphia: WILEY. |
| 2022 | Brown, Z., Hansen, D., Stevens, W., Ross, L., Ferdowsi, N., Proudman, S., . . . Morrisroe, K. (2022). Evaluation of the Distribution of Haemodynamic Parameters and Prognostic Impact in a Cohort of Patients with Systemic Sclerosis. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 4313-4315). PA, Philadelphia: WILEY. |
| 2022 | Pope, J., Proudman, S., Stevens, W., Henes, J., Simonovska, R., Alves, M., & Allanore, Y. (2022). Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) and Organ Damage: Data from the SENSCIS Trial. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 3025-3027). PA, Philadelphia: WILEY. |
| 2022 | Manning-Bennett, A., Hopkins, A., Sorich, M., Proudman, S., Foster, D., Abuhelwa, A., & Wiese, M. (2022). The Association of Cardiovascular Comorbidities with Remission in Rheumatoid Arthritis Patients Undergoing Treatment with Baricitinib and Conventional Synthetic DMARDs: A Post-Hoc Analysis. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 1796). PA, Philadelphia: WILEY. |
| 2022 | Schwender, E., Hansen, D., Stevens, W., Ross, L., Ferdowsi, N., Proudman, S., . . . Morrisroe, K. (2022). Inflammatory Arthritis in an Australian Scleroderma Cohort - Patient Characteristics, Associations and Treatments. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 4295-4297). PA, Philadelphia: WILEY. |
| 2022 | Small, A., Lowe, K., Ferrante, A., Smith, M., Proudman, S., Weedon, H., & Wechalekar, M. (2022). PHENOTYPIC PLASTICITY OF SYNOVIAL MACROPHAGES: A PROOF-OF-CONCEPT STUDY FOR A CELL-BASED TARGETED THERAPY FOR RHEUMATOID ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 12). WILEY. |
| 2022 | Callisto, A., Hansen, D., Walker, J., Ngian, G. -S., Nikpour, M., Liew, D., . . . Proudman, S. (2022). IMPACT OF THE COVID-19 PANDEMIC ON HEALTHCARE ACCESS AND ATTITUDES TOWARDS TELEHEALTH AMONG AUSTRALIAN PATIENTS WITH SYSTEMIC SCLEROSIS. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 37). WILEY. |
| 2022 | Khoo, T., Jones, B., Chin, A., Terrett, A., Voshaar, M., Hoogland, W., . . . Proudman, S. (2022). DEFINING INDEPENDENCE IN RHEUMATOID ARTHRITIS: A SCOPING REVIEW. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35-36). WILEY. |
| 2022 | Small, A., Lowe, K., Ferrante, A., Smith, M., Proudman, S., Weedon, H., & Wechalekar, M. (2022). INDUCIBLE REGULATORY SYNOVIAL MACROPHAGES: A PROOF-OF-CONCEPT STUDY FOR A CELL-BASED TARGETED THERAPY FOR RHEUMATOID ARTHRITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 81 (pp. 244-245). DENMARK, Copenhagen: BMJ PUBLISHING GROUP. DOI WoS1 |
| 2021 | Jee, A. S., Stewart, I., Youssef, P., Adelstein, S., Lai, D., Hua, S., . . . Corte, T. J. (2021). Late Breaking Abstract - A composite serum biomarker index for the diagnosis of systemic sclerosis associated interstitial lung disease: a multicentre, observational, cohort study. In EUROPEAN RESPIRATORY JOURNAL Vol. 58 (pp. 2 pages). GREECE, Thessaloniki: EUROPEAN RESPIRATORY SOC JOURNALS LTD. DOI WoS1 |
| 2021 | Small, A., Williams, K., Ferrante, A., Smith, M., Proudman, S., Weedon, H., & Wechalekar, M. (2021). Manipulation of B7 Family Member Expression Demonstrates Synovial Macrophage Plasticity and Possible Future Targets for Treatment of Rheumatoid Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 2096-2097). ELECTR NETWORK: WILEY. |
| 2021 | Sallis, O., Hansen, D., Morrisroe, K., Stevens, W., Nikpour, M., & Proudman, S. (2021). The Use of Lipid-Lowering Agents in Systemic Sclerosis: Is There a Relationship with Prevalence of Digital Ulcers and Overall Survival?. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 2855-2856). ELECTR NETWORK: WILEY. |
| 2021 | Hughes, M., Maltez, N., Brown, E., Hickey, V., Park, H., Shea, B., . . . Herrick, A. (2021). Outcome Reporting in Systemic Sclerosis-Related Digital Ulcers: A Scoping Review. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 2876-2878). ELECTR NETWORK: WILEY. |
| 2021 | Williams, K., Small, A., Song, Q., Cole, S., Hao, L. -Y., Murray-Brown, W., . . . Wechalekar, M. (2021). Programmed Cell Death Protein 1 (PD-1)-Expressing CD4+T Cells Are Expanded in Early Rheumatoid Arthritis and Correlate with Response to Treatment. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 3172). ELECTR NETWORK: WILEY. |
| 2021 | Galindo-Feria, A. S., Horuluoglu, B., Day, J., Cerqueira, C., Wigren, E., Graslund, S., . . . Limaye, V. (2021). Detection of Autoantibodies Against Muscle-Specific Four-and-a-Half-LIM Domain 1 (FHL1) in Inflammatory Myopathies: Results from a Single-Center Cohort. In ARTHRITIS & RHEUMATOLOGY Vol. 73 (pp. 1414-1416). ELECTR NETWORK: WILEY. |
| 2021 | Galindo-Feria, A. S., Horuluoglu, B., Day, J., Cerqueira, C., Proudman, S., Lundberg, I. E., & Limaye, V. (2021). DETECTION OF AUTOANTIBODIES AGAINST MUSCLE-SPECIFIC FOUR-AND-A-HALF-LIM DOMAIN 1 (FHL1) IN INFLAMMATORY MYOPATHIES: RESULTS FROM A SINGLE-CENTER COHORT. In ANNALS OF THE RHEUMATIC DISEASES Vol. 80 (pp. 697-698). ELECTR NETWORK: ELSEVIER. DOI |
| 2021 | Galindo-Feria, A. S., Horuluoglu, B., Proudman, S., Day, J., Wigren, E., Graslund, S., . . . Limaye, V. (2021). Detection of autoantibodies against muscle-specific four-and-a-half-LIM domain-1 (FHL1) in inflammatory myopathies: results from a single-centre cohort. In SCANDINAVIAN JOURNAL OF RHEUMATOLOGY Vol. 50 (pp. 67). TAYLOR & FRANCIS LTD. |
| 2021 | He, J., Sunny, L., Sallis, O., McWilliams, L., Spargo, L., Metcalf, R., . . . Proudman, S. (2021). PULMONARY FUNCTION ABNORMALITIES IN RHEUMATOID ARTHRITIS, TO SCREEN OR NOT TO SCREEN?. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 39). WILEY. |
| 2021 | Small, A., Williams, K., Song, Q., Hao, L. -Y., Murray-Brown, W., Proudman, S., . . . Wechalekar, M. D. (2021). PROGRAMMED DEATH 1 (PD-1)-EXPRESSING T CELLS ARE PATHOGENIC IN EARLY RHEUMATOID ARTHRITIS AND CORRELATE WITH RESPONSE TO TREATMENT. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 6-7). WILEY. |
| 2021 | Black, R., Lester, S., Tieu, J., Sinnathurai, P., Barrett, C., Buchbinder, R., . . . Hill, C. L. (2021). MORTALITY ASSOCIATED WITH RHEUMATOID ARTHRITIS IN AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE PARTICIPANTS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 37-38). WILEY. |
| 2021 | Sallis, O., Hansen, D., Morrisroe, K., Stevens, W., Nikpour, M., & Proudman, S. (2021). THE USE OF LIPID-LOWERING AGENTS IN SYSTEMIC SCLEROSIS: IS THERE A RELATIONSHIP WITH PREVALENCE OF DIGITAL ULCERS AND OVERALL SURVIVAL?. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 37). WILEY. |
| 2020 | Small, A., Murray-Brown, W., Guo, Y., Weedon, H., Proudman, S., Smith, M., . . . Wechalekar, M. (2020). CHARACTERISATION OF PROGRAMMED CELL DEATH PROTEIN 1 EXPRESSING PERIPHERAL T HELPER CELLS IN THE EARLY RHEUMATOID ARTHRITIS SYNOVIUM. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 42-43). WILEY. |
| 2019 | Valenzuela, A., Chung, M., Rodriguez-Reyna, T. S., Proudman, S., Baron, M., Castelino, F., . . . Chung, L. (2019). Change in Calcinosis over 1 Year Using the SCTC Radiologic Scoring System for Calcinosis of the Hands in Patients with Systemic Sclerosis. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 3 pages). GA, Atlanta: WILEY. WoS2 |
| 2018 | Boulos, D., Metcalf, R., Proudman, S., & Wicks, I. (2018). The Neutrophil-Lymphocyte Ratio in Newly Diagnosed Rheumatoid Arthritis and Its Ability to Predict Treatment Failure. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 1 page). IL, Chicago: WILEY. |
| 2018 | Day, J., Otto, S., Cash, K., Eldi, P., Hissaria, P., Proudman, S., . . . Limaye, V. (2018). Aberrant Sarcoplasmic Expression of the Alarmin 'High Mobility Group Box Protein 1" (HMGB1) in Patients with Idiopathic Inflammatory Myopathy. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 2 pages). IL, Chicago: WILEY. |
| 2018 | Reid, A., Wiese, M. D., Metcalf, R., Wechalekar, M. D., Lee, A., Hill, C., . . . Proudman, S. (2018). Utility of Serial ACPA Measurements in Rheumatoid Arthritis: Results of a Prospective Cohort Study. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 2 pages). IL, Chicago: WILEY. |
| 2016 | Guo, Y., Walsh, A., Fearon, U., Smith, M. D., Wechalekar, M. D., Yin, X., . . . Nagpal, S. (2016). Gene Enrichment Analysis Identifies Active CD40-CD40L Signaling in Early and Established Rheumatoid Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 1 page). DC, Washington: WILEY. |
| 2016 | Morrisroe, K., Huq, M., Stevens, W., Sahhar, J., Proudman, S., & Nikpour, M. (2016). Work Productivity in Systemic Sclerosis and Association with Health Related Quality of Life. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 3 pages). DC, Washington: WILEY. WoS2 |
| 2016 | Wechalekar, M. D., Lester, S., Nagpal, S., Peters, J., Dash, A., Hissaria, P., . . . Proudman, S. M. (2016). Seropositivity Predicts Bone Biomarker Change in an Inception Cohort of Rheumatoid Arthritis Patients Treated-to-Target with Combination Conventional DMARD Therapy. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 2 pages). DC, Washington: WILEY. |
| 2016 | Valenzuela, A., Gordon, J. K., Sofia Rodriguez-Reyna, T., Proudman, S., Baron, M., Hinchcliff, M., . . . Chung, L. (2016). Comprehensive Characterization of Calcinosis in a Multicenter International Cohort of Patients with Systemic Sclerosis. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 2 pages). DC, Washington: WILEY. |
| 2016 | Khanna, D., Proudman, S., Frech, T. M., Nihtyanova, S., Domsic, R. T., Berrocal, V. J., . . . Denton, C. P. (2016). Performance of Modified Rodnan Skin Score in Early Diffuse Cutaneous Scleroderma-Analysis from 4 International Cohorts. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 3 pages). DC, Washington: WILEY. |
| 2011 | Patterson, K., Sakko, A., Ricciardelli, C., Proudman, S., & Hissaria, P. (2011). EVALUATION OF ANGIOGENIC AND FIBROGENIC CYTOKINES AS BIOMARKERS IN SUBGROUPS OF SYSTEMIC SCLEROSIS. In INTERNAL MEDICINE JOURNAL Vol. 41 (pp. 9-10). WILEY-BLACKWELL. |
| 2011 | Hill, C. L., Jones, G., March, L., Battersby, R., Hynes, K., Fedorova, T., . . . Cleland, L. G. (2011). Fish Oil in Knee Osteoarthritis: A Two Year Randomized, Double-Blind Clinical Trial Comparing High Dose with Low Dose. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S426). Chicago, IL: WILEY. |
| 2011 | Ngian, G. -S., Stevens, W., Byron, J., Ai, T., Roddy, J. E., Minson, R., . . . Nikpour, M. (2011). Survival and Predictors of Mortality In Australian Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S332). Chicago, IL: WILEY. WoS1 |
| 2010 | James, M., Proudman, S., & Cleland, L. (2010). Fish oil and rheumatoid arthritis: past, present and future. In Proceedings of the 3rd International Immunonutrition Workshop Vol. 69 (pp. 316-323). UK: Cambridge University Press. DOI Scopus77 WoS66 Europe PMC52 |
| 2007 | Cleland, L. G., Caughey, G. E., Proudman, S. M., James, M. J., & Lee, A. T. Y. (2007). Fish oil treatment and cardiovascular risk in early rheumatoid arthritis. In ANNALS OF THE RHEUMATIC DISEASES Vol. 66 (pp. 347). Barcelona, SPAIN: B M J PUBLISHING GROUP. WoS1 |
| 2007 | Lee, X. T. Y., Proudman, S. M., Phillips, M., Slavotinek, J. P., & Cleland, L. G. (2007). High resolution musculoskeletal sonography in early arthritis: Can we predict outcome?. In ANNALS OF THE RHEUMATIC DISEASES Vol. 66 (pp. 94). Barcelona, SPAIN: B M J PUBLISHING GROUP. |
| 2006 | James, H., Gillis, D., Hissaria, P., Lester, S., Somogyi, A., Cleland, L., & Proudman, S. (2006). Polymorphisms in the folate pathway predict response to methotrexate in early RA.. In ARTHRITIS AND RHEUMATISM Vol. 54 (pp. S129). Washington, DC: WILEY-LISS. |
| 2005 | Marzo-Ortega, H., Green, M., Keenan, A. M., Wakefield, R., Proudman, S., & Emery, P. (2005). A randomised trial of intra-articular corticosteroids versus conservative treatment in early oligoarthritis over 12 months. In RHEUMATOLOGY Vol. 44 (pp. I90). Birmingham, ENGLAND: OXFORD UNIV PRESS. |
| 2004 | Marzo-Ortega, H., Green, M., Keenan, A. M., Wakefield, R., Proudman, S., & Emery, P. (2004). A randomised trial of intra-articular corticosteroids versus conservative treatment in early oligoarthritis over 12 months. In ARTHRITIS AND RHEUMATISM Vol. 50 (pp. S130-S131). San Antonio, TX: WILEY-LISS. WoS1 |
| 2004 | Proudman, S. (2004). Tracleer (bosentan), a dual endothelin receptor antagonist (ERA), for the treatment of pulmonary arterial hypertension (PAH) related to connective tissue diseases: Effect on quality of life (QoL). In ARTHRITIS AND RHEUMATISM Vol. 50 (pp. S692). San Antonio, TX: WILEY-LISS. |
| 1999 | Emery, P., Marzo, H., & Proudman, S. (1999). Management of patients with newly diagnosed rheumatoid arthritis. In Rheumatology Vol. 38 (pp. 27-31). England. Scopus27 Europe PMC7 |
| 1998 | Proudman, S. (1998). Aggressive combination therapy provides clinical improvement for RA. In Geriatrics Vol. 53 (pp. 67-68). |
Grants and Funding
| 2009-2012 | Identification of microRNAs in Scleroderma. | Goodall Y, Goodall G, Proudman S, Hissaria P | NHMRC Project Grant ID 626945 | $138 500 p.a. |
| 2010-2013 | Unrestricted educational grant, Actelion Australia | Proudman S, Stevens W, Roddy J, Youssef P, Gabbay E. | Australian Scleroderma Interest Group | $450 000 |
| 2011 | Therapeutic drug monitoring of leflunomide | Wiese M, Proudman S, O’Doherty, James M, Cleland L | Arthritis Australia Barbara Cameron Memorial Grant | $15 000 |
| 2011 | A novel screening biomarker in screening for PAH in SSc | Stevens W, Proudman S, Nikpour M. | Arthritis Australia project grant | $20 000 |
| 2011 | SSc serum microenvironment dysregulates endothelial progenitor cell migration and tubulogenic ability and contributes to vasculopathy | Hissaria P, Bonder C, Proudman S, Patterson K. | Arthritis Australia grant-in-aid | $20 000 |
| 2011-2014 | How are periodontal disease and rheumatoid arthritis inter-related? | Bartold M, Smith M, Haynes D, Proudman SM | App. No. 023747 NHMRC | $544,261.00 |
| 2013 | Therapeutic drug monitoring in intensive therapy for rheumatoid arthritis using methotrexate loading | Proudman SM, Wiese M | Royal Adelaide Hospital Research Foundation | $35 000 |
| 2014 | Identification of factors that influence efficacy and toxicity with leflunomide in the treatment of rheumatoid arthritis | Wiese M, Proudman SM, Shanahan M | Arthritis Australia Grant in Aid | $14, 000 |
| 2014-2016 | A Clinical Trial of Anticoagulation in Scleroderma Heart-Lung Disease | Nikpour M, Buchbinder R, Prior D, Nandurkar H, Williams T, Gabbay E, Proudman S, Nash P, Zochling J, Stevens W. | NHMRC APP1062638 | $ 1,139,571 |
| 2015 | The effect of biological agent treatment of rheumatoid arthritis on periodontal disease. | Proudman S, Bartold M | RAH Research Fund | $35 000 |
| 2015 | VCAM1 as a therapeutic target in scleroderma | Brown M, Kenna T, Proudman S, Stevens W, Nikpour M | Arthritis Australia PG422015 | $25 000 |
| 2016 | Intracellular Disease Modifying Antirheumatic Drug Concentrations in Patients with Rheumatoid Arthritis | Proudman S, Moghaddami M, Wiese M | Royal Adelaide Hospital Research Foundation | $49 118 |
Teaching
I contribute to undergraduate teaching for the University of Adelaide School of Medicine, with lectures in years 2 and 4 and clinical skills workshops in years 3 and 4. I am the coordinator of the Rheumatology component of the 4th Year Medical Student musculoskeletal teaching programme. I have been involved in year 4, 5 and 6 clinical examinations and setting and marking exam questions.
Postgraduate teaching includes tutorials, short case rounds, long cases and trial examinations for basic physician trainees and supervision of advanced trainees in rheumatology (clinical and research). I have been the advanced training supervisor for more than 15 advanced trainees, and supervised many of these in research projects which have resulted in presentations and awards at national or international meetings and publications. I have supervised two vacation students, one Honours student and three PhD students.
I have examined one Master of Philosophy Thesis (The RAGE glycine 82 serine polymorphism and cardiovascular disease in rheumatoid arthritis, L Carroll, The University of Queensland Student Number 33160957) and one PhD, Monash University 2012.
I have examined for the Australian Medical Council and I am on the National Examination Panel for the Royal Australasian College of Physicians Membership exams.
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2025 | Principal Supervisor | Improving outcomes in systemic sclerosis-related vasculopathy | Doctor of Philosophy | Doctorate | Full Time | Dr Kimti Kiran Warren |
| 2025 | Principal Supervisor | Improving outcomes in systemic sclerosis-related vasculopathy | Doctor of Philosophy | Doctorate | Full Time | Dr Kimti Kiran Warren |
| 2024 | Principal Supervisor | Investigating the association between seronegative rheumatoid arthritis, calcium pyrophosphate deposition disease and myeloid neoplasms. | Doctor of Philosophy | Doctorate | Part Time | Dr Lih En Hong |
| 2024 | Principal Supervisor | Investigating the association between seronegative rheumatoid arthritis, calcium pyrophosphate deposition disease and myeloid neoplasms. | Doctor of Philosophy | Doctorate | Full Time | Dr Lih En Hong |
| 2022 | Co-Supervisor | Rheumatoid Arthritis and Exercise in Australia | Master of Clinical Science | Master | Part Time | Dr Julia New-Tolley |
| 2022 | Co-Supervisor | Rheumatoid Arthritis and Exercise in Australia | - | Master | Full Time | Dr Julia New-Tolley |
| 2020 | Co-Supervisor | Cardiopulmonary exercise testing for screening of pulmonary hypertension in a clinical population of Scleroderma patients. | Doctor of Philosophy | Doctorate | Part Time | Mrs Sarah Ann Madigan |
| 2020 | Co-Supervisor | Cardiopulmonary exercise testing for screening of pulmonary hypertension in a clinical population of Scleroderma patients. | Doctor of Philosophy | Doctorate | Full Time | Mrs Sarah Ann Madigan |
| 2019 | External Supervisor | - | Doctor of Philosophy | Doctorate | Full Time | Mr Arkady Tobias Manning-Bennett |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2021 - 2024 | Co-Supervisor | Outcomes of Proximal Humerus Fractures in Children | Master of Philosophy (Surgery) | Master | Part Time | Mr Samuel Richard Abbot |
| 2021 - 2025 | Co-Supervisor | Artificial intelligence for the discovery of clinically relevant biomarkers in the assessment of rheumatoid arthritis | Doctor of Philosophy | Doctorate | Full Time | Dr Alix Bird |
| 2017 - 2022 | Co-Supervisor | Optimising management in ANCA-associated vasculitis | Doctor of Philosophy | Doctorate | Full Time | Dr Joanna Tieu |
| 2005 - 2010 | Co-Supervisor | Knowledge Engineering Complex Decision Support System in Managing Rheumatoid Arthritis | Doctor of Philosophy | Doctorate | Full Time | Ms Ning Pan |
| 2002 - 2008 | Co-Supervisor | Applications of Real Time Musculoskeletal Ultrasonography in Rheumatology Practice | Doctor of Philosophy | Doctorate | Full Time | Dr Anita Lee |
| Date | Role | Research Topic | Location | Program | Supervision Type | Student Load | Student Name |
|---|---|---|---|---|---|---|---|
| 2012 - 2015 | External Supervisor | OPTIMISING REMISSION AND TREATMENT OUTCOMES IN RHEUMATOID ARTHRITIS | Flinders University | Doctor of Philosophy | Doctorate | Part Time | Mihir Wechalekar |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2016 - ongoing | Member | Scleroderma Clinical Trials Consortium Scleroderma Renal Crisis working group | - | - |
| 2015 - ongoing | Member | Systemic Sclerosis 4th World Congress Scientific Committee | - | - |
| 2014 - ongoing | Member | Medical Director Arthritis Australia | - | - |
| 2014 - ongoing | Founder | The Australian New Zealand Musculoskeletal Clinical Trials Group (ANZMusc) | - | - |
| 2014 - ongoing | Chair | Australian Clinical Excellence Program Steering Committee | - | - |
| 2013 - ongoing | Member | National Examiners Panel, Royal College of Physicians | - | - |
| 2012 - ongoing | Member | Scleroderma Clinical Trials Consortium Damage Index working group | - | - |
| 2011 - ongoing | Member | Pulmonary Hypertension Society ANZ Steering Committee | - | - |
| 2011 - ongoing | Member | RAH Research Grants Committee | - | - |
| 2011 - 2014 | Member | RAH Outpatient Clinical Leadership Group | - | - |
| 2010 - ongoing | Member | Arthritis Australia Grant Review Committee | - | - |
| 2010 - ongoing | Member | Australian Clinical Excellence Program Steering Committee | - | - |
| 2009 - 2014 | Member | The Connective Tissue Disease associated Interstitial Lung Disease (CTD-ILD) working group of Outcome Measures in Rheumatology (OMERACT) | - | - |
| 2006 - ongoing | Member | Pulmonary Interstitial Vascular, Orphan transplantation (PIVOT) committee | Australian Lung Foundation | - |
| 2006 - ongoing | Chair | Australian Scleroderma Interest Group | - | - |
| 1998 - ongoing | Member | Med IV Musculoskeletal Clinical Sciences Committee | - | - |
| Date | Role | Membership | Country |
|---|---|---|---|
| 2013 - ongoing | Member | American College of Rheumatology | - |
| 2009 - ongoing | Member | Scleroderma Clinical Trials Consortium | - |
| 2009 - ongoing | Member | South Australian Salaried Medical Officers Association | - |
| 1997 - ongoing | Member | Australian Rheumatology Association | - |
| Date | Institution | Department | Organisation Type | Country |
|---|---|---|---|---|
| 2008 - 2014 | ARA Arthritis Research Trust Scientific Advisory Board | - | - | - |
Connect With Me
External Profiles
